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Many biochemical processes in which DNA and other nucleic acids participate 
are central to functions in both living cells and in molecular biology assays. While many 
compounds have been used to regulate the activity of DNA, these strategies are limited 
to the aqueous-based diffusion of the activator to the target DNA molecule.  An 
improvement to the induction of DNA bioactivity is to move to a light-based modulation.  
This research demonstrates a light-based technique using a photo-cleavable cage 
compound to transiently inactivate DNA hybridization.  Function can be restored with 
exposure to near-UV light, allowing for temporal control of DNA oligonucleotide (ODN) 
activity.  This method has demonstrated the control of hybridization in molecular biology 
assays, and provides the framework for in vivo experimentation.  A similar light-
activated strategy has been shown useful in controlling expression of plasmid 
transgenes (Monroe 1999).  By adapting this method to DNA oligonucleotides (ODNs), 
we have partially blocked hybridization with the cage compound (1-(4,5-dimethoxy-2-
nitrophenyl)ethyl ester (DMNPE) for both phosphodiester and phosphorothioate DNA 
ODNs.  The production and purification of DMNPE-caged DNA ODNs yields products 
with similar spectrophotometric properties to caged plasmids.  In hybridization studies, 
20-mer (20 base long) caged DNA ODNs were hybridized with complementary 30-mer 
molecular beacon probes, and fluorescence measurements were used to assess 
hybridization of native (non-caged), caged, and caged-light-exposed ODNs.  
Developments of the molecular beacon assays were studied to improve sensitivity of 
the assay to caged and caged-flashed ODN hybridization control. Results demonstrated 
that hybridization can be blocked and subsequently restored by light through the 
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attachment of the DMNPE cage compound, and were further characterized with gel 
electrophoresis assays.  ODN hybridization was restricted to as little as 2% when 
compared to native (non-caged) ODNs and restored to up to nearly 80% of the native 
(non-caged) ODN hybridization activity levels.  Additional studies on adduction, 
purification, and characterization of the DMNPE-caged ODNs were performed to 
optimize their production and efficacy in controlling hybridization.  These results suggest 
that this light-based technology can be used as a tool for the spatial and temporal 
regulation of hybridization-based DNA bioactivity, including applications with antisense 





 The use of nucleic acids as tools in molecular engineering and gene therapy has 
rapidly increased over recent years.  Nucleic acids have been developed into powerful 
tools to achieve many goals never before thought possible.   Recently, much of the 
focus on nucleic acids has been for their use as forms of gene therapy.  Recent studies 
have focused on the use of nucleic acids as a method for treatment for numerous forms 
of disease (Gewirtz 2001; Opalinska 2002).  When expression of genetic therapies is 
targeted to desired tissues, the treatment is safer and more efficient. 
 The overall purpose of this research is to develop a method to reversibly control 
the bioactivity of DNA oligonucleotides to spatially and temporally control gene 
expression.  Our hypothesis is that DNA oligonucleotide hybridization with a 
complimentary target can be controlled through the use of photo-cleavable cage 
compounds, such as 1-(4,5-dimethoxy-2-nitrophenyl)ethyl ester (DMNPE) until the cage 
compound is photo-cleaved from the oligonucleotides by exposure to near-UV light  Our 
study focuses on the development of this control method in vitro for DNA 
oligonucleotides with normal phosphodiester backbones as well as those with sulfur-
modified (phosphorothioate) backbones. We aim to demonstrate that reversible caging 
of the oligonucleotides is possible and efficient through the of use several qualitative 
and quantitative in vitro analyses.  We also propose to utilize temperature-varying 
assays to help provide more sensitive techniques for analysis of the ability to control 
hybridization of DNA oligonucleotides through caging.  This study is intended to provide 
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a basis for further in vivo studies of spatial and temporal control of DNA oligonucleotide 
hybridization activity through the use of cage compounds. 
Cage Compounds 
   One specific technique being employed to achieve control of nucleic acid 
hybridization, and the main focus of this research, is the use of photo-cleavable cage 
compounds. These molecules are compounds that bind to their target with a covalent, 
yet photo-cleavable bond.  Once attached to its target, the cage compound prevents the 
effector molecule from being reactive, until a time at which it is photo-cleaved and the 
effector molecule is once again reactive (McCray 1989).  It is important to note that 
these compounds do not literally encompass or form a cage around the effector 
molecule.  In reality, these molecules hinder the reactive abilities of their target by 
reducing the structural reformation of the effector molecule (McCray 1989; Pelliccioli 
2002).  Initial studies of cage compounds within biological systems focused on the 
ability to render ATP biologically inert, and then restore it to a bioactive form (Kaplan 
1978).  This task was achieved by attaching the cage compound 1-(2-nitrophenyl) ethyl 
(NPE) to the γ-phosphate of ATP.  They detected the efficacy of this strategy by sodium 
efflux measurements. The ATP was rendered inactive until exposed to 340 nm light, at 
which point consumption of the ATP was restored.  A similar basic mechanism for 
caged ATP can be seen in Figure 1.1 where the cage compound used is 1-(4,5-
dimethoxy-2-nitrophenyl)diazoethane (DMNPE).  It should be noted that DMNPE 
contains two methoxy groups attached to the 4’ and 5’ carbon atoms on the benzyl ring, 



























































Figure 1.1. Photolysis of ATP caged with a caged compound, DMNPE. 
 Since the initial experiments with ATP, numerous studies have focused on the 
use of cage compounds to control bioactivity across several platforms.  Time course 
studies of rapid responses within cells have been greatly helped by the use of cage 
compounds (McCray 1980; Gee 1998; Choi 2003).  Biologically inactive ATP can be 
introduced into cells in a biological inert form.  Upon exposure to light at rapid pulses, 
restoration of bioactivity can be achieved and the rate at which the ATP is consumed 
can be controlled and monitored. In this and many other applications, the advantages of 
using photo-protected or caged species over conventional methods for substrate 
release are that the caged species can be dispersed throughout the biological target 
without eliciting the species’ normal bioactivity, the concentration and spatial distribution 
can be controlled, and finally, the temporal release can be varied from seconds to 
nanoseconds (Givens 1998).  There have been many studies that have shown control 
of other biological processes using cage compounds within cellular studies. These have 
included transport of proteins,  and effects on biological membranes, as well as 
relaxation of muscle fibers (Patton 1991; Pirrung 1994; Ishihara 1997; Lee 1997).  The 
development of cage compounds for use within biological systems is greatly on the rise.  
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The use of caged compounds is also being further developed for aiding in control 
of gene expression and its effects on organisms. Areas of focus for the control of gene 
expression can be seen with the production of proteins (Monroe 1999; Ando 2001) and 
bioactivity of hormones (Dorai 1997; Lim 2002; Garcia-Fernandez 2003).  Several 
possible techniques are being studied to block DNA transcription and those that prevent 
translation of mRNA through degradation (Monroe; Ando 2001; Harborth 2003). 
 As the utilization of cage compounds has expanded, the structures of caging 
compounds have been developed based on their specific intended uses. Many are 
benzyl rings or derivatives with strong leaving groups, commonly bromine, chlorine, or 
diazonium, each with specific functions and preferred replacements.  Some examples of 
caging compounds are single benzyl rings, such as 1-(2-nitrophenyl)-diazoethane 
(NPE) and DMNPE, while others are multi-ring compounds such as 6-bromo-7-
hydroxycoumarin-4-ylmethly (BHC) (Furuta 1999; reviewed by Pelliccioli 2002).  In the 
case of DMNPE, this cage compound can be photolyzed by photons of wavelength 365 
nm (Monroe 1999) similar to that of BHC (Furuta 1999), which differs from those of NPE 
at 340 nm (Walker 1988).  The longer wavelength of light is beneficial for 
photoactivation in cells and tissues due to less photodamage. 
 There are few descriptions of applying caging chemistry to nucleic acids to 
temporally and spatially control function.  Cage compounds have been used in the 
caging of nucleotide analogs (Walker 1988), in the synthesis of bio-chip 
oligonucleotides (McGall 1996), in studies of the kinetics of DNA repair (Meldrum 1990; 
Meldrum 1998; Ordoukhanian 2000), and as protecting groups during DNA synthesis 






































Figure 1. 2 Proposed site of 
DMNPE adduction to DNA 
ODN. 
hairpin configuration and indirectly hybridization 
(Ordoukhanian 1995).  The use of cage 
compounds was also demonstrated in the repair of 
DNA that has a single strand break at a specific 
site (Zhang 2001).  These studies demonstrate the 
site-specific caging of a larger molecule by using 
caged building blocks in standard peptide 
synthesizers.  Cage groups have also been used 
to temporally control ribozyme and spliceosome 
activities by including caged adenosine within synthesized RNA oligonucleotides 
(Chaulk 1998; Chaulk 2001).   
Through the attachment of cage compounds, generation of translation and 
transcription products such as proteins and enzymes can be brought to minimal or no 
yield by preventing the nucleic acid from forming certain structural conformations.  
Based on the previous studies of ATP, it is theorized that the attachment of the DMNPE 
cage compound occurs along the phosphate backbone of the nucleic acid as seen in 
Figure 1.2 to a protonated non-bridging oxygen of the phosphate backbone.  
Attachment at this position is consistent with DMNPE’s attachment to other moieties 
such as carboxylic acids and phosphates, or other weak oxy acids (Walker 1988). 
In addition to controlling the kinetics of a particular molecular target, caging 
affords the ability to restrict re-activation to a localized tissue of interest, as 
demonstrated by the targeting of transgene expression by caging hormone inducers 
(Cruz 2000; Lin 2002).  Control of bioactivity through direct caging of nucleic acids has 
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been demonstrated with plasmid DNA both in vitro and in vivo by controlling transgene 
expression with light exposure (Monroe 1999).  More recently, BHC caged mRNA was 
microinjected into zebrafish embryos to induce expression of certain genes and study 
the effect of their expression on developmental patterns (Ando 2001).  This work has 
shown that the use of BHC reacted with mRNA coding for green fluorescent protein 
demonstrated a reduction in translational activity.  Once illuminated by photons, 
translational activity was restored (Ando 2003).  This shows a trend to develop 
increasingly efficient and effective caging compounds, which can be specifically 
designed to work with complementing sequences of mRNA and DNA.   We now present 
a method for controlling the hybridization activity of short DNA ODNs through the 
adduction and photo-cleavage cage compounds, thus allowing for spatial and temporal 
control of ODN bioactivity.  
Gene Therapy: Antisense 
The use of cage compounds can be noted for its effectiveness in preventing 
expression of DNA plasmids (Monroe 1999) and mRNA (Ando 2001), and current 
studies are moving in the direction of performing further tests on other nucleic acids.  
Both of the aforementioned studies focus on the use of cage compounds with antisense 
therapy technologies.  These compounds may be used with DNA  to hybridize and alter 
transcription (Monroe 1999) and mRNA to prevent translation (Dash 1987; Walder 
1988; Liebhaber 1992; Vickers 2001; Sazani 2003), thus preventing or modifying protein 
production.  While traditional drugs and therapies focus on the breakdown or control of 
proteins already produced, the antisense therapies focus on controlling the production 




Figure 1.3.  Antisense oligonucleotide 
mechanism through RNase H cleavage 
of mRNA. 
2003).  Antisense oligonucleotides have been studied for several years as treatments 
for many diseases and genetic disorders (Berg 2002; Alvarez-Salas 2003; Hugle 2003).   
Antisense therapy is based on the principles of genetic expression.  Strands of 
mRNA are transcribed from DNA, and are a copy of the “coding” or “sense” strand of 
the gene.  This main form of the therapy uses the complementary or “antisense” strand 
of the target to hybridize the “sense” 
strand and prevents production of the 
protein by blocking or altering translation.  
Another form of antisense therapy is the 
use of modified ribozymes that are 
catalytic RNA derivatives which are 
sequence specific and are involved in 
processes such as self-cleavage, ligation, 
or splicing of mRNA (Kruger 1982; 
Buzayan 1986; Hutchins 1986; Symons 
1987; Sharmeen 1988; Davies 1990).  
RNAi is another antisense technique, which functions on the premise of the production 
within cells of short interfering RNAs (siRNAs) that are effectors for targeted gene 
silencing (Fire 1998; Caplen 2001; Elbashir 2001; Elbashir 2001; Bertrand 2002; 
Miyagishi 2003). 
 One specific type of these oligonucleotides is known as antisense 
oligodeoxynucleotides or antisense ODNs, and they are designed to hybridize with a 
specific mRNA complement.  These antisense ODNS work by hybridizing to their 
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complementary or target mRNA through basic complimentary Watson-Crick base-
pairing (Paterson 1977).  Upon hybridization with the target mRNA, translation can be 
blocked through several mechanisms.  These include prevention of the mRNA from 
being processed through the ribosome (Liebhaber, Cash et al. 1992), modifying the 
splicing of the mRNA (Sazani and Kole 2003), or an impairment of the polyadenylation 
of the mRNA (Vickers 2001).  The most common mechanism of preventing translation 
through antisense ODNs is the activation of RNase-H enzyme, which will degrade the 
mRNA when complexed with the antisense ODNs (Dash 1987; Walder 1988).  Here, 
antisense ODNs are very effective in that the RNase H does not break down the ODN, 
and so they can continue to hybridize with more target mRNA.  An example of this 
mechanism can be seen in Figure 1.3. Modifications of the ODNs have become a 
necessity in order to use them for in vivo treatments.  Cellular defense mechanisms 
have influenced the efficiency of these tools through degradation of the ODNs within the 
cell by nucleases (Wickstrom 1986; Akhtar 1991).  Modifications of the ODNs to 
improve efficacy have mainly focused on backbone modifications (Chavany 1995; 
Agrawal 1997; Summerton 1997; Summerton 1997; Schmajuk 1999) and base 
modification (Kuwasaki 1996; Herdewijn 2000; Kimber 2003; Sazani and Kole 2003).  
The most widely used modified DNA in antisense therapies is phosphorothioate ODNs, 
which replaces a non-binding oxygen on the phosphate back-bone with a sulfur, as 
shown in Figure 1.4.  These modified ODNs have a much greater resistance to 
digestion by nucleases, and so have advanced the use of antisense therapies 
immensely. This modified oligonucleotide has been used with many gene therapy 
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studies and treatments (Chavany 1995; Monia 1996; Butler 1997; de Smet 1999; Yu 
2003). 
 These modified antisense ODNs are being used to help fight disease and several 
are currently undergoing FDA approval.  The first antisense treatment to get FDA 
approval to date has been Formivirsen (Vitravene), which is a treatment for 
cytomegalovirus (CMV) retinitis in people with AIDS and was developed by ISIS 
Pharmaceuticals (Roehr 1998; de Smet 1999).  Several other antisense therapies are 
undergoing FDA approval that focus on combating diseases such as HIV, malignant 
melanoma, B-cell lymphoma, colon cancer, and lung (Wong-Staal 1998; Amado 1999; 
Coudert 2001; Cripps 2002; Morris 2002; Adjei 2003).  Also, much of the research has 
recently focused on control and 
treatment of cancer.  One pathway 
that these antisense drugs are 
operating through is anti-tumor 
treatments targeting specific 
enzymes, by increasing sensitivity 
of cancer cells to apoptosis 
inducing agents, and other 
methods of destroying cells (Monia 
1996; Ohta 1996; Dorai 1997).  
Another method that antisense 
drugs are approaching treatment is by repairing or correcting improperly transcribed or 

















































Figure 1.4.  Phosphodiester ODN (left) and 
phosphorothioate modified ODN (right). 
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 One such antisense ODN, which has been very well studied and useful to caging 
research is Alicaforsen (ISIS 2302), which is being developed by the ISIS 
Pharmaceuticals. This ODN is currently being researched for its possible medicinal 
uses against Crohn’s Disease and Ulcerative Colitis (Gewirtz 2001). Its main target is 
the Intracellular Adhesion Molecule-1 (ICAM-1) gene (Bennett 1994).  The drug inhibits 
the expression of this gene, which is a key factor in many autoimmune and 
inflammatory conditions. ICAM-1 can be found in almost all cells of the human body, 
and is part of a group of molecules known as Cellular Adhesion Molecules. By 
measuring the affects of ISIS 2302 and its ability to be caged, possible control of the 
inhibition of the ICAM-1 gene’s expression in living cells can become a reality. 
 Antisense oligonucleotides although very effective, can repeatedly and 
continuously prohibit expression of the target gene, and if not controlled can lead to 
possible complications if the proteins being blocked are essential to other processes 
within a system.  In an effort to develop a control system for this, we have studied the 
use of photo-cleavable cage compounds to allow for a method to determine spatial and 
temporal aspects of drug functioning.  By attaching these cage compounds to the 
antisense oligonucleotide, hybridization to its target is blocked.  However, once exposed 
to near UV-light, the cage compound can be removed and thus fully restoring the 
antisense oligonucleotide into a fully functional form.  By this method, we allow for 
control of the antisense mechanism, while avoiding any loss of potency of the drug.  
The importance of targeting through the use of cage compounds is the need to avoid 
blockage of gene expression throughout the entire body. By using photo-cleavable cage 
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compounds, focused treatments of the antisense can be applied to specific regions of 
the body. 
Molecular Beacons 
The detection of hybridization has been an important tool for understanding the 
properties and potential of nucleic acids.  One common technique is the use of UV-
absorbance to detect the melt profiles or denaturing of nucleic acids.  This method 
functions on the hyperchromicity characteristic of nucleic acids.  Nucleic acids 
demonstrate high absorbance of light at approximately 260 nm.  Hyperchromicity is the 
principle that when double-stranded DNA or RNA denatures, the absorbance at 260 nm 
increases, and can be used to detect melting temperatures and hybridization activity.  
This technique has been utilized in studies on characterization and thermodynamic 
analysis of duplex DNA (Wu 2000), characteristics of modified nucleic acids such as 
phosphorothioate ODNs (Stein 1988) and, and DNA hairpin melt studies (Vallone 1999).  
This technique has also been employed to study the thermal effects on complexes 
formed with heteromorphic duplex DNA (Riccelli 2003).  However, this technique is 
limited to in-cuvette studies and does not allow real-time study of spatial patterns of 
hybridization in cells or tissues. 
Molecular beacons are extremely powerful tools that are being used for 
demonstrating the photo-control of hybridization activity of caged ODNs.  They allow for 
differentiation of hybridization activity between native (non-caged), caged, and light-
exposed caged ODNs through the use of fluorescence.  Fluorescence emissions from 
the molecular beacon assays can confirm hybridization activity, and thus can provide 
evidence of control of ODN activity through the attachment of photo-cleavable cage 
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                    A             B           C 
Figure 1.5.  Several forms of hybridization probes.  These are a basic molecular 
beacon (A), a TaqManTM probe (B), and a scorpion beacon (C) 
compounds.  Molecular beacons also overcome the limitations of hyperchromicity 
absorbance methods by permitting in situ detection of hybridization activity. Spatial 
control within cells can be demonstrated once studies are performed to determine the 
effects of the caged ODNs in vivo.  The beacons may also be helpful in detecting 
temporal effects of the caged ODNs by determining the presence of the target mRNAs 
and its hybridization activity within the cells. 
These probes are a revolutionary tool initially developed in 1996 by Tyagi to help 
identify nucleic acid sequences (Tyagi 1996).  Molecular beacons are short single-
stranded nucleic acids with self-complementing 5’ and 3’ ends. The stems generally are 
four to seven bases in length.  In between these self-complementing ends is the 
sequence complementary to the target of interest.  When not in the presence of the 
target, the molecular beacon takes a stem and loop form. A fluorophore and quencher 
are attached to the 5’ and 3’ ends of the oligonucleotide, respectively.  When in close 
proximity to the quencher (stem and loop form), the fluorescence emitted is absorbed, 
and little to none of it is detected.  Hybridized with its target, the fluorophore is 
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separated from the quencher, and its fluorescence can be detected as can be seen in 
Figure 1.5.  The efficacy of the beacons can be altered based on stem and loop 
sequence and by the fluorophore and quencher chosen (Tyagi 1998).  This includes 
numerous applications as discussed below including in PCR, cancer research, clinical 
and protein assays. 
PCR-based Applications 
One of the most common applications for molecular beacons is the monitoring of 
PCR reactions in real time.  By utilizing these probes in PCR, researchers can monitor 
the amplification of nucleic acids during the process (Tyagi 1996; Tyagi 1998).  When 
using these probes, they are placed into the reaction mixture, and allowed to remain 
throughout the amplification process. When at higher temperatures in the cycle, 
molecular beacons will dissociate from their hairpin loop form, however will not bind to 
the targets, and thus not interfere with amplification process.  Once temperatures have 
lowered and the amplicon extension has begun, small amounts of the beacon will attach 
to the synthesized targets and fluorescence can be detected. Any beacon that is not 
attached to the target will remain dark in its closed-stem form at these lower 
temperatures. This allows for a sensitive assay to determine the rate of amplification 
and quantify rare messages in PCR. 
 There are several advantages of this molecular beacon assay versus other 
techniques.  The use of dyes or stains such as SYBR Green and SYBR Gold (Molecular 
Probes, Eugene, OR) are limited in that they are non-specific dyes that bind to dsDNA.  
They produce signals that may not only represent the target sequence, but also 
incorrectly produced segments as well as dimers of the primers. This leads to an 
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inability to accurately determine the amount of desired target amplicons in the process.  
Several other probes have been designed to achieve a more accurate and efficient 
monitoring of the PCR process. Several of these techniques can be seen in Figure 1.5.  
TaqManTM probes are simply a probe sequence labeled with a fluorophore on each end. 
The first is a donor fluorophore and the other an acceptor fluorophore. Similar to 
beacons, the fluorophores are quenched when unhybridized to the target, and utilize 
fluorescence resonance energy transfer (FRET) to achieve this.  This technique works 
by cleavage of the TaqManTM probe when extension begins, and thus breaking up the 
probe and releasing the two fluorophores and allowing for fluorescence. The drawback 
of this technique is that the probe can only be used once, and then is rendered useless.  
Molecular beacons carry on the characteristic of multiple uses versus the single use of a 
TaqManTM probe.   Another modified version of this probe is the Scorpion primer.  Since 
the primers are directly linked to the molecular beacons in this type of probe, it allows 
for very specific to the amplicon produced since the loop section of the beacon is 
complementary to part of the desired amplicon that will be produced (Thelwell 2000; 
Taveau 2002).   
 One example of recent studies of the usage of molecular beacons with RT-PCR 
is the use of molecular beacons to detect the Y chromosome in single human 
blastomeres in an effort to determine the sex of an embryo (Pierce 2000). This has also 
been used as a technique for clone verification (van Schie 2000).  Finally there is the 
ability of the molecular beacons as tools to identify single nucleotide polymorphisms or 
SNPs (Mhlanga 2001), which is currently an intensifying area of research in the clinical 
setting due to its high specificity, accessibility, and simplicity. This is also an expanding 
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area of study in the identification of mutated genes found within small numbers of cells 
in a population, leading to a great range of uses for this technology (Vogelstein 1999). 
 One of the greatest advantages that accompanies the use of molecular beacons 
is multiplexing. The idea of using a multiplex of molecular beacons is quite simple and 
quite an advance in comparison to previously used assays. Since molecular beacons 
have an extremely high specificity with the ability to distinguish between single 
nucleotide mismatches in a target sequence, multiple beacons can be used to 
accurately identify several variants of target sequences with as little as a single base 
difference.  These probes also have great advantage over other fluorescence stains 
such as SYBR Green (Molecular Probes, Eugene, OR) in that they can report specific 
complementary targets, while SYBR Green and other dyes are non-specific DNA 
binding dyes.  An initial study by Marras  (1999) probed the accuracy of detection of four 
molecular beacons, each with different fluorophores, and each differing by as little as 
one single nucleotide. This study demonstrated the ability to actively differentiate the 
presence of a specific variant of an amplicon present quickly and efficiently (Marras 
1999).  Many other studies demonstrated the ability of using multiplexed molecular 
beacons to quickly and accurately identify specific strains of influenza (Templeton 
2003), several types of bacteria (Belanger 2002; Templeton 2003; Varma-Basil 2004), 
and numerous viruses (Vet 1999; Klerks 2001; Szemes 2002).  The use of these 
techniques with quantitative PCR (Q-PCR) can allow researches to quantitatively 
determine the levels of specific targets within samples, and thus utilize this in many 
numerous ways.  
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In the following sections, adaptations of molecular beacons towards immobilized 
and other clinical uses will be presented to further underscore this development in the 
technology. 
Thermodynamic and Kinetic Properties 
As probes and diagnostic tools, molecular beacons are well known for their 
specificity.  The ability for molecular beacons to distinguish between nucleic acids with a 
difference of as little as one base pair have been studied since these tools were initially 
published by Tyagi and Kramer in 1996.  In comparison to linear probes, the hairpin 
stem of the molecular beacons allows for much more selectivity when identifying nucleic 
acids by reducing the background fluorescence produced by an non-hybridized probe 
(Tyagi 1998).  Since the hybridization of the molecular beacon to its target can be 
manipulated, this allows for the improvement of the ability of the beacons to identify 
their targets even in the presence of nucleic acids that may differ by as little as a single 
or double base mismatch. 
 This specificity is affected by several conditions including pH, salt concentration, 
and temperature. It has been shown that the negative effect of a single mismatch on the 
free energy when two strands of nucleic acids hybridize decreases as the length of the 
strands increases. A single base mismatch will have more effect on preventing 
hybridization the shorter the strands of nucleic acids (Aboul-ela 1985).  This principle 
can be seen in molecular beacons, as they are generally short oligonucleotides of about 
30 – 40 nucleotides in length.  By adjusting the hybridization conditions, one can easily 
improve the ability of these probes to identify their targets with a high level of selectivity.  
Of the earlier stated conditions, temperature is the most easily and dynamically 
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controlled condition to manipulate hybridization reactions.  Several studies have 
provided insight into the thermodynamics and kinetics of molecular beacons (Bonnet 
1999; Tsourkas 2002). 
There are three forms in which molecular beacons can exist.  These three forms 
are the hybridized duplex, self-hybridized in the hairpin structure, and un-hybridized yet 
randomly coiled (Bonnet 1999).  The likelihood of each state is based on the presence 
or absence of the target and the reaction conditions, most notably temperature. By 
altering the temperature, the probes will change their form between the three forms 
previously mentioned. At temperatures above the melt temperatures of the hybridized 
duplex, the probes exist in the un-hybridized, randomly coiled form.  As the temperature 
cools in the presence of the target, hybridized duplexes of the probe and target will 
become more likely along with self-hybridized hairpin forms of the molecular beacons.  
Because of the free energy “tax” of a single base mismatch in short oligonucleotides, 
such as the 25-mer molecular beacons shown in the Bonnet (1999) studies, these melt 
temperatures are much lower. In their study, the single base mismatch was placed in 
nine different positions within the target sequence to determine the point at which the 
lowest “tax” on free energy would be present (Bonnet 1999). The mismatch with the 
lowest strain on the hybridization was the mismatch farthest from the center mismatch, 
and had a melt temperature near 31 °C. This differed greatly than that of the 
complementary target, which had a melt temperature of approximately 42 °C.  As can 
be seen in Figure 1.6, once the melt temperature was exceeded, fluorescence rapidly 
reduces, thus making the detection of the complementary target even more specific.  
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Figure 1.6.  Temperature profiles of molecular beacon hybridizations with 
perfect target, one base mismatch, two base mismatches, and molecular 
beacon alone (MB1 alone) along with the beacon phases for temperatures. 
Other studies have focused on the effects of thermodynamic and kinetic 
conditions on molecular beacon hybridization to their targets (Tsourkas 2002; Tsourkas 
2003).  These studies display that not only does the length of the sequence being 
targeted determine the specificity of the probe, but also the length of the stems, as well 
as their composition have great effect on the selectiveness of the probes to identify their 
exact targets. Studies showed that beacons dependent on location, number of 
mismatches, and lengths of stem altered the specificity of the probe to identify its 
complementary target.  Probes with a stem length of four nucleotides showed much less 
specificity than those of five or six nucleotides.  The probes with stems of six 
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nucleotides in length also showed an ability to show greater specificity at lower 
temperatures.  Not only did stem lengths affect the amount of fluorescence detected 
when these probes were hybridized with their targets, they also varied in the amount of 
time required for the probes to reach their maximum fluorescence. The shorter the 
stem, the higher the overall fluorescence and the shorter the amount of time required to 
reach that fluorescence level. This trend alone can be important in designing the 
probes, based on the response time sought by the user. One final trend noted in these 
studies shows that as stem length increased, melting temperature of the hybridization 
duplex reduced.  The differences, however, begin to narrow as the probe length 
increases (Tsourkas 2003). 
In 2002, Tsourkas . published a study showing the kinetics of a shared stem 
molecular beacon versus a conventional molecular beacon(Tsourkas 2002). The 
initiative was to determine whether a more stabilized fluorophore would help to improve 
the use of two molecular beacon systems.  The shared stem molecular beacons have 
one stem (in this case the stem attached to the fluorophore) that participates in both the 
formation of the hairpin as well as the probe target hybridization.  This forces the 
fluorescent dye into a much more constrained position and thus allows for more control, 
as opposed to random coiling that is seen with traditional probes. The results of this 
study demonstrated that the melting temperature of the shared stem beacon was higher 
for both the complementary target and the single mismatch target, thus leading to a 
stronger hybridization between target and probe in the case of the shared stem probe 
(Tsourkas 2002). These kinetic and thermodynamic characteristics of molecular 
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beacons provide insight into the potential of these probes in the field of function-specific 
probe design.  
Clinical Applications 
As we have discussed, there are many possibilities for the use of molecular 
beacons as diagnostic tools in many facets of the scientific community. A promising 
application for molecular beacons is to detect disease or mutated DNA within an 
organism.  The use of such technology would allow for more accurate and much more 
rapid results when attempting to diagnose a patient.  Many studies have been focused 
on the use of molecular beacons in the detection and identification of viruses (Lewin 
1999; Szuhai 2001; Kostrikis 2002; Jebbink 2003).  Several studies have also focused 
on the use of these molecular tools for diagnosing and helping with the treatment of 
cancer as well (Arnold 1999; Span 2003; Culha 2004). 
Many studies have utilized molecular beacons to detect pathogens (Chen 2000; 
Fortin 2001; Lanciotti 2001; Belanger 2002).  These studies utilize the principles of 
amplification of target DNA through PCR and then utilize beacons to identify the 
presence or absence of targets. These probes have also been utilized in research for 
quantifying viral loads and the replications of viruses through similar studies (Lewin, 
Vesanen 1999; Yates 2001; Yang 2002).  The high specificity of molecular beacons to 
discriminate between bases with as little as single base differences in their sequences 
provides researches with a versatile tool. One particular study has been to quantify viral 
loads of the Human Immunodeficiency (HIV), Hepatitis C (HCV), and Hepatitis B (HBV) 
viruses with the ability to detect viral loads of as low as 50 copies/mL in the case of HIV 
and HBV, and 20 IU/mL of the HCV virus (Abravaya 2003).  The two most noted 
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characteristics that make the molecular beacon a great diagnostic tool are the reduction 
in contamination from post-PCR manual handling and short time required to run the 
tests.  
Use of molecular beacons along with RT-PCR has been used as a tool to 
diagnose and discriminate between many bacteria, such as Bordetella pertussis, 
Bordetella parapertussis, and Bordetella Holmessi (Templeton 2003). Earlier studies of 
the ability of molecular beacons as tools to diagnose infectious diseases demonstrated 
this ability with the respiratory infectious agent Mycobacterium tuberculosis (El-Hajj 
2001) and sexually transmitted infectious agents Chlamydia Trachomatus (Zhang 
2002).  This was also demonstrated in a study for the detection of the presence of 
several species of Salmonella through the use of RT-PCR and molecular beacons 
(Chen 2000).  The trend to develop assays as diagnosis for infectious diseases has 
since greatly increased as the use of such a tool in clinical settings poses such great 
advancement in health care treatment.   
The capability of molecular beacons to be used as genetic assays for other 
diseases such as Tay-Sachs has also been demonstrated (Rice 2002).  This study 
utilized the probes to detect the specific alleles for single copy genes found within a 
single cell.  By lysing these cells and amplifying the nucleic acids properly through PCR, 
one molecular beacon was used to detect the presence of either a normal allele, while 
the other was used to detect the 4 base-pair insertion mutated allele, which is one of the 
more prominent mutations known to account for a high percentage of Tay Sachs 
carriers.  This study showed a very accurate detection rate of over 99.1% with a run 
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time of only three hours, thus showing that the use of molecular beacons greatly 
increased the efficiency of detection of the gene mutation (Rice 2002). 
 Recent studies have also been focused on the use of molecular beacons as a 
diagnostic tool for cancer.  As a rapid, accurate, and specific diagnostic tool, molecular 
beacons serve as a great tool for early detection of mutations in genes that can lead to 
cancer. One example of this is the study by Culha . from 2003 in which they have 
shown the use of molecular beacons on a miniature biochip for detection of the BRCA1 
gene. As one of the genes known for leading to increased susceptibility to breast cancer 
if mutated, early detection and identification is an important tool in prevention (Culha 
2004).  The use of a molecular beacon based RT-PCR assay has also been 
demonstrated as a valid tool with a predictive value when studying breast cancer (Span 
2003).  This use of molecular beacons with RT-PCR has also been significant in 
studying the proteins associated with breast cancer and the ability for metastasis with a 
tumor by allowing for detection of the presence of the proteins and their amounts within 
the breast cancer. This leads to the conclusion that higher amounts of these proteins 
within cancer cells can increase likelihood of metastasis (Arnold 1999). 
Applications for molecular beacons as tools with regards to cancer however, 
have not been limited solely to breast cancer research.  Several studies have focused 
on lung cancer as well as a variety of other variations.  One example here is the use of 
molecular beacons to detect the presence of K-ras point mutations in an effort to 
determine predisposition for the illness.  Using molecular beacons to both detect the 
sense and anti-sense strands of the K-ras Exon 1 compared with the commercially 
available elucigene K-RAS7 method showed that this type of assay provides an 
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accurate and rapid way to screen large numbers of samples in an effort to get early 
detection (Clayton 2000).  Another technique has shown that by simply using human 
hair shafts and single nucleotide polymorphism PCR, researchers can perform analysis 
of genotype by using molecular beacons to identify genomic predisposition to diseases 
such as cancer (Chang 2002).  This technology provides an opportunity for quick and 
non-invasive screening of individuals for genetic mutations that may lead to a greater 
likelihood of developing a disease, and thus can be treated to attempt to prevent the 
onset of those illnesses. 
Project Aims 
 The overall purpose of this project is to apply the use of photo-cleavable cage 
compounds to reversibly control the hybridization activity of DNA oligonucleotides.  This 
method would provide the basis for spatial and temporal control of the activity of such 
specialized ODNs as antisense ODNs, providing a path for overcoming a drawback of 
the antisense strategy by allowing for targeting of the ODNs to specific tissues within a 
system.  The use of cage compounds to afford a light induced control of the ODNs 
hybridization activity may provide a simple method for improved drug delivery and more 
focused and powerful treatments.  Another aim of this project is the development of in 
vitro assays in order to help provide evidence of the reversible caging effect.  This is 
specifically focused on the development of molecular beacon assays based on this 
tool’s high level of sensitivity.  Molecular beacons provide a window for potent screening 
of the temporal control achieved by caging of ODNs with photo-cleavable cage 





Control of DNA Hybridization with Photo-cleavable Adducts 
Introduction 
The hybridization of nucleic acids with their complementary strands is a rate-
limiting step in many biological processes and bioassays including fluorescence in situ 
hybridization (FISH), microarrays, polymerase chain reaction (PCR), DNA-based 
biosensors, molecular computing, RNAi and nanomachines. Strategies to enhance, 
limit, or trigger these biological processes often target the hybridization event. It is well 
known that the extent of DNA hybridization is significantly dependent on temperature 
and ionic environment, and changes in these have therefore been used to control 
hybridization. Examples of temperature control are hot-start methods commonly used in 
PCR.  Ionic environmental control of hybridization has been demonstrated through 
environmental modulation of salts or metal ions (Barnes 2002).  Recent work 
accomplished spatial and temporal control through inductive coupling of 
oligonucleotides to metal nanocrystals that provide local heating when exposed to an 
external radio frequency field in order to have a broader ability to manipulate biological 
functions (Hamad-Schifferli 2002). Here we describe another strategy to control 
hybridization of nucleic acids with other forms of energy that enable precise regulation 
at the onset.  Light was used to activate oligodeoxynucleotides (ODNs) that were 
previously inactivated with 1-(4,5-dimethoxy-2-nitrophenyl)diazoethane (DMNPE), a 
photocleavable “cage” compound that has been shown to control bioactivity of DNA 
plasmids (Monroe 1999).   
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Caged compounds have a covalently attached group that can be photocleaved 
when exposed to specific wavelengths of light.  The “caged” term describes the 
blockade of biological activity rather than a chemical structure(McCray 1989; Pelliccioli 
2002).  Some studies that have shown control with caged compounds are seen within 
cellular studies, which include transport of proteins, effects on biological membranes, as 
well as muscle fibers (Patton 1991; Ramesh 1993; Ishihara 1997; Lee 1997). Caged 
compounds have been used to study the time course of fast cellular processes induced 
by a millisecond step increase in the intracellular concentration of a bioactive compound 
of interest achieved by a pulse of light exposure.  In many of these applications, the 
advantages of using photoprotection over conventional methods for substrate release 
are that the caged effectors can be dispersed throughout the biological target without 
eliciting the species normal bioactivity, the concentration and spatial distribution can be 
controlled, and finally, the temporal release can be varied from seconds to nanoseconds 
(Givens 1998).  
Photoactivatable compounds have been used modulate many aspects of DNA 
chemistry and biology. O-nitrobenzyl cage compounds were originally used as a 
protecting group in organic synthesis (Pillai 1980).  Caged compounds have now been 
adapted and used in the caging of nucleotide analogs (Walker 1988), in the synthesis of 
bio-chip oligonucleotides (McGall 1996), in studies of the kinetics of DNA repair 
(Meldrum 1990; Meldrum 1998; Ordoukhanian 2000), and as protecting groups during 
DNA synthesis (Alvarez 1999).  Cage groups have also been shown to control an 
oligonucleotide hairpin configuration and indirectly hybridization (Ordoukhanian 1995).  
The use of cage compounds has also been seen in the repair of DNA that has a single 
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strand break at a specific site (Zhang 2001).  Inclusion of caged adenosine within 
synthesized RNA oligonucleotides enables temporal control of ribozyme and 
spliceosome activities (Chaulk 1998; Chaulk 2001).  
We have also shown that direct caging of plasmid DNA with DMNPE can block 
transcription, allowing for the targeted expression of transgenes in vitro and in vivo 
through direct light exposure (Monroe 1999).  In addition to controlling the kinetics of a 
particular molecular target, caging affords the ability to restrict re-activation to a 
localized tissue of interest, as demonstrated by the targeting of transgene expression by 
caging hormone inducers or nuclear receptor agonists (Cruz 2000; Lin 2002; Link 
2004).  More recently, caged mRNA was microinjected in zebrafish embryos to induce 
expression of certain genes and study the effect of their expression on developmental 
patterns (Ando 2001; Ando 2003).  In this report, we explore the application of 
photoactivatable cage compounds to reversibly block hybridization of DNA 
oligonucleotides. 
Materials and Methods 
ODN Caging with DMNPE  
Unless otherwise specified, reagents were purchased from Sigma-Aldrich (St. 
Louis, MO).  5 mg of 1-(4,5-dimethoxy)-2-nitroacetophenone hydrazone (Molecular 
Probes, Eugene, OR) and 50 mg of manganese (IV) oxide were gently agitated in 1 mL 
of N,N-dimethylformamide (DMF) at 25 °C for 20 min.  Manganese oxide was removed 
from the 1-(4,5-dimethoxy-2-nitrophenyl) diazoethane (DMNPE) by filtering the solution 
through 100 mg of CeliteTM supported by glass wool in a 1 cc tuberculin syringe barrel.  
100 µl of the filtrate was agitated with 100 µg of the ODN (2µg/µL) in 200 µl of 10mM 
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Bis-Tris (pH 5.5) for 1 hour at 4 °C.  Another 60 µl of the active 1-(4,5-dimethoxy-2-
nitrophenyl)-diazoethane (filtrate) was then added and the solution was agitated for 24 
hours at 4 °C.   
A second set of caging reactions was run in triplicate using phosphorothioate 
ODNs (PS-ODNs).  This reaction followed the same procedure as stated above, 
however only the initial 100 µl of active DMNPE cage compound was added prior to 
overnight agitation. Samples were filtered and then characterized in the same format as 
the initial set. 
To remove excess unattached cage compound, caged ODNs were purified using 
Microcon YM-3 (3000 MW cut-off) centrifugal filters (Millipore, Bilerica, MA).  Caged 
ODNs were spun at 12x103 G for 100 minutes, and then resuspended in 33% DMF, 
stored at 4 °C, and protected from light by wrapping samples in aluminum foil.   
Spectral Scanning Protocol and DMNPE Extinction Coefficient Determination 
Absorption spectrophotometry of caged species was used to estimate the degree 
of caging.  Native (non-caged) 20-mer ODN (GCCCAAGCTGGCATCCGTCA, 
purchased from Integrated DNA Technologies, Coralville, IA) and DMNPE-caged ODN 
were dissolved in 33% DMF in separate cuvettes (DMNPE-caged ODN: 50 µg/ml; 
native ODN:  50 µg/ml) and scanned for absorbance from 230 to 500 nm (Thermo 
Spectronic Genesys 6, Waltham, MA).  Spectral scans of caged-flashed ODNs (caged 
ODNS exposed to light) were also made similarly to the above stated methods. To 
determine the spectral changes following photoactivation, some of the caged-flashed 
ODN products were filtered through the Microcon YM-3 filters following light exposure to 
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remove the released 1-(4,5-dimethoxy-2-nitrosophenyl)-ethanone, and then scanned as 
described.  These samples are referred to as caged-flashed-filtered ODNs.   
To approximate the extinction coefficient of DMNPE adducted ODNs, 
absorbance peaks at 260 and 355 nm of known concentrations of dilutions of DMNPE-
caged ATP in 33% DMF were scanned as above.  Moles of DMNPE present were 
calculated and the amount of 260 nm absorbance attributed to the DMNPE cage 
molecules in the spectra of caged ODNs was determined.  These values were then 
used with Beer’s Law to calculate ODN concentration and caging efficiency using the 
following: 
Equations 1 & 2:  
• A260 nm = [(ε260 nm, DNA)(CDNA)(L)] + [(ε260 nm, DMNPE)(CDMNPE)(L)]           (1) 
  
• A355 nm = [(ε355 nm, DMNPE)(CDMNPE)(L)]           (2) 
     - C  = Concentration (M) 
         - ε   = Extinction coefficient (M-1.cm-1) 




• Phosphate Caging Efficiency (Cageeff = percent of phosphates caged) 
 
• Cageeff   = [(CDMNPE ÷ CDNA) ÷ (# of Bases in ODN)] * 100       (3) 
Photoactivation and Gel Electrophoresis of Caged ODNs 
 ODN (250 ng) was run in a 15% polyacrylamide non-denaturing gel in tris-borate 
(TBE) buffer (100 mM tris-borate, 2 mM EDTA, pH 8.5) at 70 V for 80 minutes.  Caged-
flashed samples were prepared by taking aliquots from the 50µg/ml caged-ODN 
samples and exposing 365 nm light (dose equivalent to 5.6 mJ/cm2) for 20 minutes prior 
to electrophoresis.  The light source has a peak output at 365 nm and a fluence rate of 
4.68 mW/cm2 at 10 cm (UVP Blak Ray, San Gabriel, CA; Model B 100 AP).  
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Spectrographic characterization of this lamp confirmed that the emission spectrum is 
365 nm ± 8 nm (USB2000 Fiber Optic Spectrometer, Ocean Optics, Inc., Dunedin, FL).  
Gels were stained after electrophoresis with 1X SYBR-Gold nucleic acid gel stain 
(Molecular Probes, Eugene, OR) in TBE buffer for 30 minutes. A polyacrylimide non-
denaturing gel was also run identically in order to characterize the resulting samples of 
caged and caged-flashed phosphorothioate ODNs. 
Hybridization of ODNs to Complementary Molecular Beacons 
In order to determine the role that DMNPE adduction plays in the disruption of 
hybridization of the ODN to complementary DNA or RNA, a hybridization assay using 
molecular beacons was developed.  Molecular beacons are fluorogenic probes that 
signal hybridization with a complementary nucleic acid target (Tyagi 1996).  These DNA 
oligonucleotides contain a 5’ fluorophore, a 3’ quenching group, and 4-6 complementary 
bases on the 3’ and 5’ “stem” ends, which cause the beacon to form a hairpin structure. 
Unless the inner “loop” region hybridizes to a complementary nucleic acid, the 
fluorescence of the beacon in its hairpin configuration is quenched (Figure 2.1).  When 
hybridized with a complementary ODN, the hairpin structure linearizes, distancing the 
fluorophore from the quencher generating fluorescence (Bonnet 1999).   
 A molecular beacon (MB1) was designed to hybridize with the specified ODN 
used in this experiment (Monroe 2003).   The sequence of MB1 was designed with the 
aid of mfold, an RNA/DNA folding analysis program (Zuker 2000) and synthesized by 
Biosearch Technologies (Novato, CA). The sequence of molecular beacon 1 (MB1) is 
5’-FAM-gtgcgTGACGGATGCCAGCTTGGGCcgcac-BHQ1-3’, where capital letters 



















































Figure 2.1. Hybridization assay of caged probe and complementary molecular 
beacon.  Non-hybridized molecular beacon assumes the stem-loop 
configuration (A) and does not show fluorescence.  When hybridized to a 
complementary nucleic acid target, the beacon fluoresces (B).  Caged 
oligonucleotide does not hybridize with molecular beacon (C) until 
photoactivated with 365nm light (D).  Inset shows theoretical location of 
adduction of DMNPE cage molecule at phosphate backbone of the ODN. 
indicate bases forming the stem region of the beacon.  The quenching group in this 
beacon is BlackHoleQuencher-1 (BHQ1) and the fluorescent label is [(3',6'-
dipivaloylfluoresceinyl)-6-carboxamidohexyl]-1-O-(2-cyanoethyl)-(N,N-diisopropyl)-
phosphoramidite (FAM).   
 Hybridization of caged and native ODNs with molecular beacon was performed 
as follows: 630 ng of native (non-caged), caged, or caged-flashed ODN were mixed with 
300 ng of complementary molecular beacon (3.6:1 ODN:Beacon molar ratio) in 100ul 
solutions of 100 mM NaCl, 1mM EDTA, pH 7.5.  The mixtures were denatured at 90°C 
for 5 min and allowed to slowly cool to 25°C over 60 min.   
A similar hybridization experiment was also run in order to determine the effects 
of caging on the phosphorothioate ODNs.  Some changes were noted as only a 1x ratio 
as run in order to determine the effects.  Samples were otherwise prepared identically to 
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the procedure described above. 
Fluorescence Measurements of Molecular Beacons 
Fluorescence of hybridization solutions was used to quantify the hybridization of 
molecular beacons with ODNs.  Each hybridization mixtures (100 µL) was excited at 
492nm and emitted fluorescence quantified at 515nm in triplicate with a LS55B 
Luminescence Spectrophotometer (Perkin Elmer, Boston, MA).   
A functional quantum yield (Φ) was calculated, based on the increases in 





=Φ      (4) 
 
where I is the irradiation intensity in moles of photons cm-2 s-1, ε is the decadic 
extinction coefficient of DMNPE in cm2 per mole of substrate, and t90% is the irradiation 
time in seconds for 90% conversion (Adams 1988).  A value of 4795 M-1cm2 was used 
for the 355 nm molar extinction coefficient for DMNPE that was calculated as described 
in “spectral scanning protocol”. 
Electrophoresis of Caged ODNs and Molecular Beacons 
Standard gel electrophoresis was used to confirm hybridization of caged ODNs 
with complementary molecular beacons. 210 ng of the ODN-molecular beacon 
hybridization mixture was run at 70V in 15% non-denaturing polyacrylamide in TE buffer 
(4 mM tris-borate, 0.1 mM EDTA, pH 8.5) for 90 min.  Gels were stained in 1x TBE 
buffer for 30 minutes as previously described in the non-denaturing gel electrophoresis 
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assay with the nucleic acid stain of Sybr Gold.  Samples were then visualized under UV 
light. 
Results 
Absorbance Spectrophotometry  
Figure 2.2 shows 
the absorbance spectra 
of DMNPE-caged ODN, 
caged-flashed (caged-
light exposed) ODN, 
caged-flashed-filtered, 
and native (non-caged) 
ODN.  Unlike native 
ODN, DMNPE-caged 
ODN has a 
characteristic 
absorbance peak at 355 nm, consistent with the attachment of the DMNPE cage 
compound (Walker 1988).  Based on the extinction coefficient of attached DMNPE, an 
average number of DMNPE caging groups per ODN was calculated as described 
previously, but here we also account for the 260nm absorbance of DMNPE due to 
higher adduction rates of DMNPE to ODNs than required to inactivate DNA plasmids  
(Monroe 1999).  Absorbance at 355 nm indicates that caged ODN has approximately 
14-16 DMNPE cage groups per 20mer ODN.  Once flashed, a shift can be noted in the 
355 nm peak that broadens towards longer wavelengths.  The absorbance of the 
 
Figure 2.2. Spectral scans of DMNPE-caged, caged- 
Flashed, caged-flashed-filtered, and native PS-ODN. All 
three samples were dissolved in 33% DMF in separate 
cuvettes and scanned for absorbance from 230 to 500 nm.   
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released cage group prevents estimation of photoactivation by spectrophotometry, so 
some samples were filtered to remove the released cage and then scanned again. The 
caged-flashed-filtered ODN product results in an even lower absorbance with a similar 
trend in the range of 350 to 370 nm. The caged-flashed-filtered ODN has approximately 
2-4 DMNPE cage groups per ODN. 
Non-denaturing Gel Electrophoresis 
Electrophoresis of caged ODNs shows characteristic changes in mobility 
corresponding to the addition and 
removal of the DMNPE caging groups 
(Figure 2.3).  The DMNPE-caged 
oligonucleotides have reduced mobility 
compared to that of native 
oligonucleotides. A light-induced 
change is seen between the caged 
and caged-flashed samples, with the 
caged-flashed band having mobility 
more comparable to the native ODN 
subjected to caging conditions and processes of the caging reaction, but without the 
addition of DMNPE.  The intensity of the band corresponding to the caged ODN was 
also less than the caged-light-exposed and native ODNs, suggesting an alteration of the 
ODN that interferes with its staining. 
In Figure 2.4, the native phosphorothioate ODN does however electrophorese 
much closer to the 20 base pair marker in the molecular ruler, thus showing a reduced 
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Figure 2.3.  Non-denaturing gel 
electrophoresis of DMNPE-caged and native 
phosphodiester ODNs.  Caged-flashed 
samples were exposed to 5.6 mJ/cm2 of 365 















mobility.  Also, very little staining is seen in the caged phosphorothioate ODN compared 
to native phosphorothioate ODN, corresponding to a greater amount of cage compound 
attached to the ODNs.  Restoration of the ODNs to mobility and staining characteristics 
closer resembling that of the native ODN can be seen with the light induced shift 
between the caged and caged-flashed samples. 
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Figure 2.4.  Non-denaturing gel 
electrophoresis of DMNPE-caged and native 
phosphorothioate PS-ODNs.   
 
Fluorescence Measurements of Hybridization Products 
Fluorescence emissions from a complementary molecular beacon indicate 
differing amounts of hybridization for caged and native ODNs (Figure 2.5). The relative 
fluorescence of molecular beacon in solution alone was 34.6 ± 9.4 (mean ± SD, n=3) 
relative fluorescence units (RFUs) and 414 ± 34 RFUs when native compliment was 
added. Fluorescent emission of the hybridization mixture of caged ODN and molecular 
beacon is 89.2 ± 8.3 RFUs, which is 14.4% of the relative fluorescence of the native 
probe hybridization mixture when background signal of molecular beacon alone in 
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exposed sample shows an increase in fluorescence to 336 ± 8.0 RFUs, which is 79.5% 
of the native solution, indicating an increase in hybridization of the photoactivated 
ODNs.  Significant difference from beacon alone is denoted by the cross symbol, while 
asterisks denote significant difference from both caged ODN and beacon alone (n = 3, 
p<0.05, Bonferroni’s t-test). 
 
In the case of the phosphorothioate caged ODNs in comparison, restriction of 
hybridization by the cage compound was much greater than that of the phosphodiester 
ODNs. As seen in Figure 2.6, the relative fluorescence for the molecular beacon alone 






















Figure 2.5.  Relative fluorescence intensities from solutions of molecular beacon 
hybridized with phosphodiester native, caged or caged-light-exposed ODNs.  
630 ng of native, caged, or caged-light-exposed ODNs were mixed with 300ng 
of molecular beacon (3.6:1  target:beacon molar ratio) and tested for 
hybridization in a fluorescence spectrofluorimeter. Significant difference from 
beacon alone is denoted by cross symbol, while asterisks denote significant 
difference from caged ODN also (n = 3, p<0.05, Bonferroni’s t-test). 
































emission of the caged ODNs in this set of samples was 61.4 ± 0.7, or 0.88% of the 
native solution when the background noise is removed as stated above.  Once again, 
when exposed to UV-light of 365 nm, the activity is restored, although not as greatly as 
with the phosphodiester samples.  The caged-flashed ODN in this experiment had a 
fluorescence of 217 ± 6.7.  This is equivalent to a restoration of the ability to hybridize of 
the sample to 17.8% from 0.88%, which is over a 20-fold increase of hybridization from 
caged to caged-flashed ODNs. 
 
 






























Figure 2.6.  Relative fluorescence intensities from solutions of molecular beacon 
hybridized with phosphorothioate native, caged or caged-light-exposed ODNs.  630 ng of 
native, caged, or caged-light-exposed ODNs were mixed with 300ng of molecular beacon 
(3.6:1 target:beacon molar ratio) and tested for hybridization in a fluorescence 
spectrofluorimeter. Significant difference from beacon alone is denoted by the cross 
symbol, while asterisks denote significant difference from caged ODN and beacon alone 





Non-denaturing Gel Electrophoresis of Hybridization Products  
 To confirm the results from the solution measurements of molecular beacon 
hybridization, non-denaturing polyacrylamide electrophoresis was used to show gel 
mobility shifts upon hybridization with caged and caged-light-exposed ODNs.   Note the 
changes in the hybridized duplex and non-hybridized ODN band intensities between 
caged and caged-flashed samples (Figure 2.7, lanes 2 & 3).  Caged ODN does not 
completely hybridize with its complementary sequence on the molecular beacon.  
However the sample that was exposed to light shows more ODN in the duplex form, 
resembling that of the non-caged native probe hybridization (shown for comparison in 
                                                            
 




Figure 2.7.  Inverse image of non-denaturing gel of hybridization products from 
caged and caged-flashed samples of hybridized oligonucleotides. Changes in 
hybridization of native, caged and caged-flashed mixtures of probe ODNs and 
molecular beacon were analyzed for changes in intensity of the band 
corresponding to the duplex conformation.   
10 bp Ladder 
Caged-Flashed ODN & 
Molecular Beacon (MB)
Caged ODN & MB 
Native ODN & MB 
30 mer Molecular 
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Lane 4).  The non-hybridized molecular beacon does not stain well when run in a gel at 
these concentrations, possibly due to the beacon’s quenching of the nucleic acid stain 
used (lane 5). 
Light dose-response of caged ODNs and Molecular Beacons 
 
To determine the proper dose of light exposure required for photoactivation of 
caged ODNs, hybridization mixtures were exposed to increasing durations of light 
before denaturating and fluorescence measurement (Figure 2.8).  Fluorescence 
emission increased with increasing light exposure, from 230 RFU with no light 
exposure, to values of 302, 325, 344, 372 and 380 RFU with light exposures of 1, 2, 5, 
10, and 20 minutes, respectively.  Significant difference from caged ODN (0 minutes) 
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Figure 2.8.  Effect of cumulative light exposure time on solution 
fluorescence of caged ODN-molecular beacon hybridization 
mixtures, with times of 1, 2, 5, 10, and 20 minutes. Significant 
difference from caged ODN (0 minutes) denoted by asterisks (n = 3, 






denoted by asterisks (n = 3, p<0.05, Bonferroni’s t-test).  All of the samples showed a 
significant difference from the control sample.  The experimental data retrieved from this 
section was utilized to determine the functional quantum yield for the caging of ODNs 
with DMNPE (see Equation 4).  
Discussion 
Our data suggests that the adduction of photocleavable cage compounds to DNA 
oligonucleotides (ODNs) can reversibly block hybridization.  This strategy relies on the 
covalent attachment of a cage compound, which disrupts DNA bioactivity until 
photocleavage restores DNA to its native and bioactive form. We have partially blocked 
ODN bioactivity with the cage compound DMNPE, the same compound that has been 
shown to reversibly control transcriptional activity of plasmid DNA (Monroe 1999).    
Absorbance data and gel shifts indicate that DMNPE adducts to ODNs and is 
photocleaved with 365 nm light.  Spectral scans show characteristic absorbance at 355 
nm (Figure 2.2).  Similar to DMNPE-caged plasmid DNA and DMNPE-caged ATP, 
absorption at this wavelength is consistent with the presence of DMNPE caging groups, 
as native DNA does not absorb in this region.  Calculations based on the extinction 
coefficient of attached DMNPE indicate that there is an average of 14 to 16 cage 
molecules present per 20-mer ODN. The spectral scans in Figure 2.2 also indicate that 
photo-cleavage of the caged ODNs was achieved. The filtration of the flashed products 
(caged-flashed-filtered) confirms this as the absorbance at the 355 to 390 nm range 
decreases once the sample was filtered. By filtering the caged-flashed product, 
released cage could be removed, and thus a more effective characterization of the 
flashed product was possible. In gel electrophoresis, caged ODNs have lower 
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electrophoretic mobility than native (non-caged) ODNs (Figures 2.3 & 2.4).  This 
observation is consistent with the attachment of the non-polar DMNPE cage groups that 
retard ODN mobility by neutralizing otherwise negative charges on the phosphodiester 
backbone or base structures.  It was originally hypothesized that the DMNPE attaches 
to the phosphate backbone of DNA, similar to its demonstrated attachment to 
phosphates of nucleotides (Walker 1988).  While structural studies of the DMNPE-
caged ODNs have not been completed to date, alterations in staining intensity between 
caged and native ODNs (lanes 2 and 3) suggest that attachment of the DMNPE may 
also block some reported base-associated labeling of the SYBR-Gold nucleic acid stain 
used to visualize these ODNs in gels (Tuma 1999). Even if the majority of DMNPE 
adduction occurs at the phosphate backbone of the ODN, this conformation may still 
disrupt hybridization, as shown with other phosphate modifications (Jeong 1999). 
Two assays utilizing molecular beacons demonstrate that caging ODNs modified 
their hybridization activity.  The switch-like fluorescence properties of the molecular 
beacon allow it to act as a direct measure of hybridization, so that solutions of 
hybridized ODN and beacon can be assayed for hybridization directly in a 
spectrofluorimeter.  Fluorescence emission of a hybridization mixture of caged ODNs 
and complementary beacon is much lower than that of the native hybridization mixture 
(Figures 2.5 & 2.6).  When exposed to 5.6 J/cm2 of 365 nm light prior to hybridization, 
fluorescence emission increases, indicating a restoration of hybridization activity.  When 
the background of native probe alone is subtracted, the level of activity between the 
caged and caged-light-exposed ODN-beacon hybridization increases from 15% to 79% 
of the native ODN’s activity. This was also the case in the hybridizations run with the 
 41
phosphorothioate caged ODNs.  However in this case, a much higher suppression of 
the ODN was achieved at 0.88% and restored to 17.8%, or over a 20-fold restoration.  
To corroborate the results found in solution, molecular beacons were also used in a 
non-denaturing PAGE assay, to show shifts in gel bands upon hybridization (Figure 
2.7).  Decreased intensity of the band representing the duplex hybridization of 20mer 
ODN and 30-mer molecular beacon shows that caged ODN does not completely 
hybridize with a complementary beacon.  When exposed to 365 nm light prior to 
hybridization and electrophoresis, cage groups are photocleaved from the ODN allowing 
it to hybridize.  The caged-light-exposed sample showed a stronger band in the duplex 
conformation resembling that of the non-caged native probe hybridization.  The 
presence of a stronger band of the 20-mer non-hybridized ODN in the caged sample 
that disappears in the flashed sample also confirms the alteration of hybridization 
activity seen in solution. 
Restoration of hybridization of caged ODNs is a light-dependent process as seen 
in the 365 nm light dose response of hybridization activity in Figure 2.8.  An exponential 
relationship is seen between the amount of fluorescence from a molecular beacon and 
increasing light exposure, with a dose1/2 of 0.288 J/cm2.  It is difficult to compare this 
dose of light with other photolysis studies because most caged compounds are directly 
synthesized with only one cage moiety per effector molecule.  However, the doses for 
functional restoration of DMNPE-caged ODNs do appear to be within the range of other 
published values of photolysis for similar cage compounds and light delivery systems 
(Rossi 1997; Rinnova 2000).  The caging group used here, DMNPE, in general has 
relatively low quantum yields when compared to other caged groups.  For instance, the 
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reported Qp for DMNPE-caged ATP is 0.07, much lower than the 0.63 Qp of NPE-caged 
ATP (Walker 1988; Wooton 1989).  An attempt to estimate the functional quantum yield 
of DMNPE-caged ODNs was made based on the increase in functional activity with light 
exposure in the beacon assay in Figure 2.8.  The measured increase in hybridization 
was used to determine complete conversion rather than the traditional method of 
quantum yield determination from absorption increases.  The fact that each caged ODN 
has multiple DMNPE adducts precludes the simple use of an absorption increase 
because restoration of hybridization may not correlate with the photoconversion of less 
than all the attached cages.  Our calculations indicate that DMNPE-caged ODNs have a 
functional quantum yield of at least 0.09.  This number assumes a 100% response from 
the molecular beacon to indicate hybridization of a photoreleased ODN, which may not 
be the case.  Lower efficiencies of the molecular beacon system in detecting 
hybridization of a photoactivated ODN would impart increases to the resulting quantum 
yield.  
Modifications of the strategy could lead to improvements in blockade and 
subsequent restoration of hybridization of ODNs.  Since our initial report of caging 
plasmid DNA with DMNPE, other promising cage groups have been identified.  For 
example, brominated 7-hydroxycoumarin-4-ylmethyls (BHC), a modification of Tsien’s 
bromocoumarin cage, has recently been used to randomly cage mRNA, allowing it to be 
activated at selected sites for translation in zebrafish embryo’s, facilitating the 
elucidation of several genes involved in development (Ando 2001).  BHC reportedly has 
better quantum efficiencies than DMNPE, which would require less light for complete 
photocleavage after delivery to cells (Furuta 1999).  In addition to a lower light dose, the 
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architecture of light exposure to tissue could be engineered to minimize cellular-induced 
responses, while maximizing total dose of light delivered to the caged ODNs.  Two-
photon excitation could be an alternative technique for photoactivation of caged ODNs 
(Piston 1999).    Longer wavelengths utilized in the two-photon uncaging have lower 
energy than the 365 nm light, causing less photodamage to cells and tissues (Denk 
1995).  The longer wavelengths also have deeper tissue penetration and would allow 
targeting at greater depths. This technique, combined with newer cage molecules 
having biologically useful 2-photon cross-sections, could minimize cellular damage 
while increasing targeting precision (Furuta 2004).  
A significant improvement in this strategy would be to cage a single nucleotide 
and incorporate it into ODN synthesis.  This approach offers the advantage of 
controlling precisely the number and attachment site of cage groups to each ODN.    It 
is also possible that different attachment sites of the caging moiety on the ODN will 
have different rates of photorelease.  If the caging sites which give the highest efficiency 
of photorelease could be identified, caging conditions or synthetic strategies to 
incorporate the cage in a site specific manner can be developed to target those 
positions which are most readily released upon irradiation.   
In summary, our data indicate that light-activated hybridization can be achieved 
with the use of photocleavable cage compounds.  Spectrophotometric, gel-shift, and 
molecular beacon fluorescence data indicate that caged compounds can be used to 
reversibly alter the hybridization activity of single stranded DNA.  Attachment of DMNPE 
to phosphodiester ODNs presents a strategy for the temporal and spatial control of 
hybridization.  This strategy has application in controlling DNA hybridization activity 
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such as primer activity in PCR, FISH, microarrays, molecular computers, 
nanomachines, DNA-biosensors and targeting of antisense ODNs to specific locations 
in tissues.  Extension of this technique to phosphorothioate ODNs and RNAi species 
could be applicable in controlling gene silencing and protection of these compounds 









The aim of this study is to determine an optimal solvent and purification 
technique combination to allow for effective and efficient characterization of DMNPE-
caged ODNs.  Selection of an appropriate solvent is necessary to allow for a consistent 
and potent reaction, while also allowing for proper characterization of the caged 
products.  Determination of the optimal purification technique is an important step in 
providing a valid assessment of the cage compounds abilities to control oligonucleotide 
hybridization activity.  Presence of excess cage does not allow for proper assessment of 
the purification method, and may have negative effects in future in vivo studies.   
In an effort to improve efficiency of the caging reaction and characterization of its 
products, we chose to look at the effects of different solvents in the caging reaction of 
DMNPE with DNA oligonucleotides (ODNs) as previously described in chapter 2.  
Proper solvent selection was necessary to promote cage attachment, avoid denaturing 
and irreversible alterations of the DNA, provide separation of products from unattached 
cage compound, and to facilitate accurate characterization.  Study of the effects of 
solvents such as N,N-dimethylformamide (DMF) or dimethyl sulfoxide (DMSO) on 
nucleic acids has shown denaturing through activity of endonuclease S1 (Wetmur 
1968).  DMSO has also recently been used for the reaction of cage compounds with 
nucleic acids in an effort to develop a photo-control method for hybridization (Monroe 
1999; Ando 2001).   
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DMNPE has minimal solubility in water (Walker 1988), and thus is problematic 
when working with ODNs aqueous solutions.  In studies on caging of DNA plasmids, 
33% dimethyl sulfoxide was used in mixture with a 10mM Bis-Tris solution, allowing for 
solubility levels that were adequate to keep the caged DNA plasmids in solution 
(Monroe 1999).  However, more heavily caged samples are more likely to precipitate in 
an aqueous solution, due to higher amounts of the hydrophobic cage compound.  It was 
also noted that DMSO would crystallize at 4ºC in the reaction, thus preventing a full 
reaction from taking place when used with DNA ODNs.  DMF was initially chosen to 
replace DMSO, as they share very similar properties and DMF does not crystallize at 
4ºC.  One drawback of using DMF, however, is the high extinction coefficient of the 
solvent at wavelengths of 200 to 260 nm, thus providing possible difficulty in accurately 
characterizing the ODNs.   Four organic solvents, chosen based on previous use or 
compatibility with materials used, 
were evaluated to determine the 
optimal choice for caging DNA ODNs 
with DMNPE: N,N-
dimethylformamide (DMF), 
isopropanol (IPA), methanol 
(MeOH), and acetonitrile (MeCN).  
Structures of these solvents can be seen in Figure 3.1. 
Purification of the caged ODN products upon completion of the chemical reaction 
was also studied.  The presence of excess cage compound required separation of the 

















Figure 3.1. Structures of Solvents tested. 
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extractions and ethanol precipitations by Monroe (1999) with DNA plasmids, this 
technique was not efficient at separation of the caged and native DNA ODNs from the 
excess cage compound due to the greater degree of DMNPE adduction with the more 
heavily caged products portioning into the organic phase.  This was most notable with 
the phosphorothioate DNA ODNs, which were more reactive with the cage compound 
when compared to the phosphodiester DNA ODNs.  In order to account for this issue, a 
study was run to determine an efficient method for purifying the reaction volumes.  The 
three methods studied were the use of Slide-a-Lyzer dialysis (Pierce Biotechnology, 
Rockford, IL), Sephadex G-25 Oligo Quick Spin columns (Roche, Basel, Switzerland) 
and Microcon YM-3 molecular weight cut-off filters (Millipore, Bilerica, MA).  Upon 
completion of this study, optimal caging reactions could be performed and 
characterized, thus allowing for an efficient investigation of the ability to control DNA 
ODN hybridization with DMNPE. 
Materials and Methods 
DMNPE Cage Compound Solubility 
 DMF, isopropanol, methanol, and acetonitrile were tested to determine the 
solubility of DNA oligonucleotides (ISIS 2302) and DMNPE cage compound.  In order to 
determine the solubility of the cage compound in the organic solvents, a 5 mg sample of 
1-(4,5-dimethoxy)-2-nitroacetophenone hydrazone (DMNPE hydrazone) was dissolved 
in 1 mL of DMF, and aliqouted into 50 µL volumes that were then dried down to 5 µL 
and resuspended in 300 µL of MeCN, DMF, IPA, or MeOH.  Spectrophometric scans of 
these samples were then performed from 200 nm to 500 nm (baselined in their 
respective solvent) in order to determine solubility. 
 48
To determine whether activated DMNPE has differing solubility in these solvents, 
the DMNPE hydrazone solution used above was activated using 35 mg of MnO2, 
followed by covering the samples in aluminum foil.  The samples were then vortexed for 
15 seconds followed by agitation at 4 ºC for 20 minutes. The samples were then placed 
in a microcentrifuge for 30 seconds and filtered through 100 mg of Celite supported by 
glass wool to remove the MnO2.  After filtration, a second set of aliquots was made as 
described in the initial DMNPE solubility study from the activated solution. These 
samples were then dried and resuspended to a volume of 300 µL in one of the solvents 
and scanned in the spectrophotometer as previously described.  
DNA Oligonucleotides in Various Solvents 
DNA ODNs were dissolved in either pure solvents or 33%, 50%, 66% mixtures of 
each with HPLC grade water in order to determine solubility. Previously made solutions 
of both phosphorothioate and phosphodiester 20-mer ODN (ISIS 2302) were initially 
diluted in water to 50 µL at a concentration of 0.05 µg/uL and dried down in a vacufuge 
at 30 ºC to a final volume of 5 µL.  Samples were then resuspended, one of each type 
of ODN in the four aforementioned pure solvents up to a volume of 300 µL and scanned 
in a spectrophotometer as previously described. 
DNA Oligonucleotides in Mixed Solvents 
 Based on the results of the initial experiment, further samples were prepared with 
acetonitrile or methanol in mixture with water as solvents.  100 µL samples of the DNA 
ODNs (0.05 µg/uL) were each brought up to 300 µL in final volume by adding one of the 
solvents and water to make solutions of 33%, 50%, and 66% of each organic solvent in 
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water.  These samples were then scanned in the spectrophotometer as in the previous 
experiment to determine sample solubility.   
Purification Technique Evaluation 
To determine the most efficient method of purification, two caging reactions (300 
µg of DNA ODN, 300 µL of activated DMNPE) were run following the protocol located in 
Appendix B, one with phosphodiester DNA ODNs and the other with phosphorothioate 
DNA ODNs.  Three 300 µL aliquots of each completed reaction were then prepared.  An 
additional standard reaction was also run with phosphodiester DNA ODNs for 
comparing a second protocol used with the Microcon YM-3 filter with additional washes 
to help improve removal of the unattached DMNPE.  Samples were then scanned in a 
spectrophotometer and characterized quantitatively.  Working stocks were prepared for 
each reaction at a concentration of 50 µg/µL, and then analyzed in molecular beacon 
hybridization and gel electrophoresis assays following the same methods found in 
chapter 2. Samples were compared and analyzed to determine which purification 
technique was the most promising in several categories, such as volume, duration, 
ODN recovery, and cost.  
Variable Solvent Caging Reaction 
 Three caging reactions were performed as stated in chapter 2 with various 
solvents in place of DMF.  This reaction was run in DMF, MeOH, and DMSO.  Samples 
of DMNPE hydrazone were activated in each of the solvents, and then the reaction was 
performed accordingly.  The cage sample was then reacted with both phosphodiester 
and phosphorothioate ODNs.  Samples were only reacted with 100 µL of active 
DMNPE.  In all steps of the reaction and subsequent purification, DMF was replaced 
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with the solvent of choice.  Upon completion of the reaction and purification, 
spectrophometric scans were taken and samples were assessed in molecular beacon 
hybridization identical to protocol in chapter 2. 
Results 
DNA Solubility in Solvents 
 
Figure 3.2 shows the 
absorbance spectra of 
phosphodiester DNA ODNs 
(PD ODNs) in each of the 
four organic solvents.  
These four solvents were 
N,N-dimethylformamide 
(DMF), acetonitrile, 
isopropanol, and methanol.  
It was noted that very little 
to no absorbance is seen at 
a wavelength 260 nm, the 
characteristic peak for 
DNA.  The predicted 
absorbance in water for this 
concentration would have 
been between 0.3 and 0.4 
with a concentration of 0.01 
Wavelength (nm)
















Figure 3.2. Spectrophotometer scans of Phosphodiester 
DNA ODNs in several organic solvents. 
Wavelength (nm)

















Figure 3.3. Spectrophotometer scans of 
Phosphorothioate DNA ODNs in several organic 
solvents. 
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µg/µL.  In Figure 3.3, the same experiment showed the absorbance spectra of 
phosphorothioate DNA ODNs (PS ODNs).  In this case, a confirmed peak at 260 nm for 
the DMF sample was observed, while a visible peak was noted for the methanol 
sample.  This however was not the case in the acetonitrile and isopropanol samples. 
The next step in the study looked at the solubility of the two types of DNA ODNs 
in solvents of a mixed nature.  The two solvents studied here were acetonitrile and 
methanol.  DMF was not tested as it is shown that the ODN is soluble in the solvent in 
Figure 3.3.  In Figure 3.4, samples of PD ODNs were in mixtures of methanol, and all 
remained similar to the spectrum in water.  The PD ODNs behaved similarly in 
acetonitrile, however these samples were slightly more variable in their absorbance 
near 260 nm as can be seen in Table 3.1. There was also a slight shift in the peak, 
however this was very minimal and within one to two nm.  The PD-ODNs in DMF also 
behaved similarly. 
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Figure 3.4. Spectrophotometer Scans of Phosphodiester 
DNA Oligonucleotide Solubility in Methanol Mixtures.  
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Looking at Table 3.1, phosphorothioate ODNs followed a similar spectra to that 
of the phosphodiester ODNs although there was more variation between the peaks the.  
Some unique trends in the phosphorothioate samples were seen with acetonitrile 
mixtures. The 33% acetonitrile sample had a higher peak than the 50% sample, 
however the 66% sample is higher than both, but all are within the error of the 
spectrophotometer. This was the same case for the DMF samples.  
Table 3.1. 260 nm absorbance for ODNs in DMF, methanol and acetonitrile mixtures. 
Solvent Mixture Phopsphodiester ODN 
260 nm Absorbance 
Phosphorothioate ODN 
260 nm Absorbance 
Water 0.98 1.14 
33% Methanol 1.01 1.28 
50% Methanol 1.04 1.34 
66% Methanol 0.96 1.37 
33% Acetonitrile 1.12 1.31 
50% Acetonitrile 1.05 1.24 
66% Acetonitrile 1.03 1.45 
33% DMF 1.08 1.11 
50% DMF 1.23 1.30 
66% DMF 1.07 1.27 
 
DMNPE Solubility in Solvents 
In Figure 3.5, the 
spectrophotometer scans of the 
DMNPE hydrazone are shown for 
each solvent.  In this case, it was 
important to look at the absorbance 
at 355 nm as the key indicator of 
DMNPE solubility.  Figure 3.5 
showed that all solvents provide 
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Figure 3.5. Spectrophotometer scans of DMNPE 
hydrazone in organic solvents.  
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relatively the same peaks at 355 
nm and 260 nm for the inactive 
DMNPE hydrazone.  This was also 
the case for the activated DMNPE 
compound (Figure 3.6), where 
there was little difference from that 
of the inactive DMNPE hydrazone.  
All samples had very similar peaks 
and shapes at the 260 nm and 355 
nm wavelength regions. 
 
Spectrophometric Scans of Purification Technique Reactions 
The spectrophotometer 
scans in Figures 3.7 (PD ODN) 
and 3.8 (PS ODN) below provided 
initial characterization of the 
efficiency to purify caged DNA 
oligonucleotides.  Peaks for DNA 
were at approximately 260 nm, 
while DMNPE peaks were 
accounted for at both 355 nm and 
260 nm. In Figure 3.7, the highest 
260 nm was achieved by the 
Microcon YM-3 filter, while it also 
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Figure 3.6. Spectrophotometer scans of active 
DMNPE cage compound in organic solvents.  
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Microcon YM-3 Filter + Washes
Figure 3.7.  Spectrophotometer scans of caged 
phosphodiester DNA ODN after various filtration 
techniques.  
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had the highest 355 nm peak. The Microcon YM-3 filter’s 355 nm absorbance dropped 
dramatically when the extra washes were performed, while it also maintained most of its 
260 nm peak.  
The caged phosphorothioate ODNs behaved slightly different as is shown in 
Figure 3.8.  Here, the 260 nm peak for the Microcon YM-3 filter was once again the 
highest.  The 260 nm peak of the G-25 Sephadex filter showed very little PS-ODN 
present, and also had a relatively low 355 nm peak.  The 355 nm peaks of the other two 
filters however varied greatly showing a much lower peak for the Slide-a-Lyzer. 
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Figure 3.8. Spectrophotometer scans of caged 
phosphorothioate DNA oligonucleotide after various 
filtration techniques.  
 
Table 3.2. Caging reaction characteristics for various filtration techniques. 
ODN Type & Purification 
Technique 
Perceived Caging 
Efficiency % Yield of ODN 
PD Sephadex 65.38% 56.0% 
PD Dialysis 77.44% 22.4% 
PD Amicon  113.7% 106.5% 
PD Amicon with washes^ 38.11% 93.4% 
PS Sephadex 85.8% 22.0% 
PS Dialysis 106.6% 37.2% 
PS Amicon 169.3% 82.0% 
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ODN yields and perceived caging efficiencies for each purification technique 
were calculated from the spectrophotometer scans identically to those performed in the 
previous chapter and displayed in Table 3.2.  Since aliquots from the same reaction 
were used with each technique, the actual caging efficiency remained the same for all.   
Variations are entirely based on the presence of unattached DMNPE and the DNA 
retained in the purified samples.  The total amount of oligonucleotide was out of an 
initial 100 µg of DNA oligonucleotide.  Caging efficiency was determined by the amount 
of cage present and number of possible binding sites available in the solution as 
described in chapter 2.  Values for caging efficiency greater than 100% indicated an 
excess of unattached DMNPE cage compound not filtered from the sample.  This could, 
however, also have been due to the cage compound binding to sites other than the 
predicted sites along the phosphate backbone.  Higher caging efficiencies with 
phosphorothioate ODNS could possibly be due to a difference in extinction coefficient 
when attached to the sulfur atom as well as possible complications with purification 
methods.  It was noted that as the reaction was visibly more active for phosphorothioate 
ODNS with greater N2 gas production and a much quicker color change of the reaction 
volume from red to yellow. 
Gel Electrophoresis of Purification Technique Reactions  
 Gel electrophoresis of the caged ODNs showed the normal characteristic 
changes in mobility and staining normally attributed to adduction and photo-release of 
the DMNPE cage compound for all of the techniques.  PD caged samples (Figure 3.9) 
all behaved similarly with reduced staining and mobility.  Upon exposure to light, the 
staining and mobility of all samples were partially restored.  
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Figure 3.9.  Non-Denaturing Gel Electrophoresis of 
DMNPE-caged and native PD-ODNs 
C = caged sample, F = Caged-flashed Sample.  
S = G-25 Sephadex filter, D = Slide-A-Lyzer Dialysis, 
and A = Microcon YM-3 Filtered samples. 
  
The same trend was seen in the gel electrophoresis results for the PS ODNs 
displayed in Figure 3.10.  In this gel, the most improved restoration of staining ability 
was attained from the samples run through the G-25 Sephadex filter.  It should be noted 
that very little of the actual DNA was recovered during the G-25 Sephadex purification,  
and so required a greater amount of the sample to bring it to the desired concentration. 
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Figure 3.10.  Non-Denaturing Gel Electrophoresis of 
DMNPE-caged and native PS ODNs.   
C = caged sample, while F = Caged-flashed Sample.  
S = G-25 Sephadex filter, D = Slide-A-Lyzer Dialysis, and  
A = Microcon YM-3 Filtered samples. 
 57
Fluorescence Measurements of Molecular Beacon Hybridization Products 
Fluorescence emissions of samples hybridized with the molecular beacon 
provide evidence as to the ability of the DMNPE cage compound to control 
hybridization.  As seen in Figure 3.11, the purified caged PD ODNs for each technique 
showed reduction in hybridization with the molecular beacon.  A background noise 
value of the molecular beacon alone was of 32.4 relative fluorescence units (RFUs), 
while the solution containing the native PD ODN and the molecular beacon had a very 
high value of 490 RFUs. The caged samples all ranged from a low value of 62.9 to a 
high of 69.4 RFUs.  Once exposed to UV-light of 365 nm in wavelength, all three 
samples recovered some ability to hybridize with the molecular beacon ranging from 





















R.F. 32.4 490 69.4 268 66.3 258 62.9 220
MB1 Native S-C S-F D-C D-F A-C A-F
 
Figure 3.11. Molecular beacon hybridization assay of caged 
PD ODN samples. 
C = Caged Sample F = Caged-Flashed Sample 
S = Sephadex Filtration, D = Dialysis Filtration, and  
A = Amicon Filtration 
 
This was not the case in the run containing the phosphorothioate ODNs.  As can 
be seen in Figure 3.12, restoration of the capacity to hybridize was negligible, however 
the cage compounds prevention of hybridization was greater in the case of the PS 
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ODNs.  Previous experiments as shown in Figure 2.6 of chapter 2 have provided some 
evidence that PS ODNs can be successfully caged and then restored with exposure to 
light. The difference between the two sets of experiments was the use of follow up 











Various Solvent Caging Reactions:  Fluorescence Measurements of Molecular 
Beacon Hybridizations  
 
Fluorescence emissions from a complementary molecular beacon indicate 
differing amounts of hybridization for caged and native PD-ODNs in various solvents 
(Figure 3.13). The relative fluorescence of molecular beacon in solution alone was 27.0 
± 0.7 (mean ± SD, n=3) relative fluorescence units (RFUs) and 440 ± 15 RFUs when 
native compliment was added. Fluorescent emission of the hybridization mixture of 
caged ODN (DMF) and molecular beacon is 90.7 ± 5.1 RFUs, which is 15.4% of the 
relative fluorescence of the native probe hybridization mixture when background signal 























R.F. 32.4 766 42.1 68.3 31.4 54.6 44.5 56.1
MB1 Native S-C S-F D-C D-F A-C A-F
 
Figure 3.12. Molecular beacon hybridization assay of caged PS 
ODN samples. 
C = Caged Sample F = Caged-Flashed Sample 
S = Sephadex Filtration, D = Dialysis Filtration, and  
A = Amicon Filtration 
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The caged-light-exposed ODN (in DMF) showed an increase in fluorescence to 231 ± 
4.2 RFUs, which is 49.4% of the native solution, indicating an increase in hybridization 
of the photoactivated ODNs.  In the case of ODNs in DMSO, the caged ODN showed a 
fluorescence of 77.0 ± 1.1 RFUs or 12.1% the activity of native ODN, while caged-light-
exposed ODNs had a fluorescence value of 164 ± 8.1 RFUs or 33.2% of native activity. 
The last samples were studied with methanol as a solvent.  The caged-ODN in this case 
had a relative fluorescence of 365 ± 6.8 RFUs or 81.8% activity of native, where as the 
caged-light-exposed ODNs had an increased fluorescence of 397 ± 13.4 RFUs or 
89.6%. Significant difference from beacon alone denoted by crosses asterisks, while 












































































Figure 3.13. Molecular beacon hybridization assay of caged PD-









In the case of the phosphorothioate caged ODNs in comparison, restriction of 
hybridization by the cage compound was much greater than that of the phosphodiester 
ODNs. As seen in Figure 3.14, the relative fluorescence for the molecular beacon alone 
was 27.0 ± 0.7, while the native ODN had a fluorescence of 391 ± 9.8.  The 
fluorescence emission of the caged PS-ODNs in DMF was 31.3 ± 0.5, or 1.18% of the 
native solution when the background noise is removed as stated above, while the 
caged-light-exposed PS-ODNs had a relative fluorescence of 68.7 ± 3.5 or a value of 
11.5% activity.  Samples in DMSO faired similarly with a fluorescence of 39.0 ± 2.0 
RFUs (3.30% activity) for caged PS-ODNs and 67.4 ± 2.2 RFUs (12.5% activity) for 
caged-light-exposed ODNs.  Phosphorothioate samples tested in methanol (MeOH) 
behaved differently 
than PD-ODNs in 
methanol with a 
caged-ODN 
fluorescence of 
49.5 ± 0.6 RFUs 



























































Figure 3.14. Molecular beacon hybridization assay of caged 
PS-ODN samples in various solvents. Significant difference 
from beacon alone denoted by crosses asterisks, while 
asterisks denote significant difference from caged ODN and 
beacon alone (n = 3, p<0.05, Bonferroni’s t-test).  PS-ODN 
caged in DMF showed insignificant difference when compared 




Data indicates that solvent choice did have an effect on the efficiency and ability 
to characterize the ODN caging reactions.  In the chapter 2, we demonstrated that use 
of the DMNPE cage compound allowed for temporal control of the ODN’s hybridization 
activity.  By optimizing the solvents, we were able to ensure the most promising cage 
attachment, purification, and performance of light-activated hybridization.  The initial 
step of this study was to identify the solvent that could replace dimethyl sulfoxide 
(DMSO), which was previously used with plasmid DNA caging (Monroe 1999).  Due to 
its relatively high freezing point, and the preferable reaction of DMNPE with the DNA 
ODNs at 4 ºC, DMSO was limiting in the efficiency of the caging reaction.   
The initial focus of this study was to determine the solubility of the cage 
compound (DMNPE) and ODNs in several solvents.  It was also necessary to determine 
whether the ODNs and cage compound could be accurately characterized in the 
solvents.  Figure 3.5 shows that the inactive DMNPE hydrazone is soluble in all of the 
solvents tested.  The 355 nm peaks does show similar solubility in the different solvents.  
Similar results were noted when the activated samples of DMNPE were scanned as can 
be seen in Figure 3.6, and so this leads us to determine that DMNPE is adequately 
soluble in all of the solvents studied.  
Next, it was necessary to determine whether the DNA oligonucleotides would be 
soluble in these solvents. The results of phosphodiester ODN samples are shown in 
Figure 3.2. They demonstrated very little solubility in any of the solvents including DMF. 
In Figure 3.3, it was observed that again very little solubility was noticeable in the 
solvents, with the exceptions of DMF and slightly in methanol. At this point, methanol 
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and acetonitrile were evaluated with mixtures of 33%, 50%, and 66% of each with water 
and made from native phosphodiester and phosphorothioate ODN stocks. DMF 
mixtures were also showed adequate solubility of the DNA oligonucleotides.  
As shown in Figure 3.4 and Table 3.1, phosphodiester DNA ODNs showed 
solubility in all of these mixtures for both solvents. This was also the case with the 
phosphorothioate DNA ODN samples demonstrated in Table 3.1 as absorbance at 260 
nm was very close for all samples. In the case of acetonitrile mixtures, the solvent was 
extremely volatile, and thus some higher peaks at 260 nm for the higher percentage 
acetonitrile solutions could be attributed to reduction in volumes by evaporation, which 
lead to higher concentration solutions.  Quick evaporation of the acetonitrile samples 
was noted in more than one of the samples.  However, a fairly consistent region of 
peaks was observed in all samples, providing a solid starting ground for utilizing these 
solvents to improve characterization of the caged oligonucleotides.  The spectral 
interference found with DMF is not found with any of the other solvents.  Due to its high 
absorbance of light at 260 nm, there is a reduction in the accuracy of the spectral scans 
taken for the ODNs. This was not noted as an issue with the other solvents studied.  
Table 3.3 below displays the solvents and their characteristics in several categories 
including solubility of DNA in mixtures of solvents, solubility of cage compounds, 
compatibility with filters, and spectral interference they may have.  
One focal point for these solvents was their compatibility with the purification techniques 
used.  Isopropanol was initially eliminated with no solubility of DNA as expected.  
Unfortunately, the high volatility of acetonitrile made it unsuitable with many of the 
filtration systems.  DMF in low percentages was compatible with the filters.  Methanol, 
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although seemingly compatible, was unable to adequately activate the DMNPE when 
suspended entirely in methanol (Figures 3.13 and 3.14), nor was the caging reaction 
itself very efficient when compared to that of DMF and DMSO.  Figures 3.13 and 3.14 
also demonstrate a greater restoration of activity for DMF when compared to DMSO. 
DMF has a restoration of activity by 3.2 and 9.7-fold for PD-ODNs and PS-ODNs, 
respectively, as compared to 2.7 and 3.8-fold restoration in DMSO samples. This 
limitation lead to us to chose DMF as the solvent of choice with high reactivity of the 
cage compound and ODNs in the solvent.  
Table 3.3. Solvent Compatibility Comparison. 












Water +++ X + +++ +++ 
DMF* +++ +++ +++ + + 
MeCN* X +++ +++ X +++ 
MeOH* + +++ +++ + +++ 
100% IPA X +++ X X +++ 
• * = Mixtures of solvent and water 
• +++ = Compatible     ++ = Moderate     + = Slight     X = Incompatible 
 
We next focused on determining the optimum technique for purifying the samples 
upon completion of the reaction.  It is important to recall that prior to filtration, the 
samples used were completely identical.  Looking at the results of the purification 
technique study, Figures 3.7 and 3.8 showed the spectral analysis of the samples after 
they were purified. Figure 3.7 shows the spectral scan for the phosphodiester ODN 
samples, with the highest absorbance at 260 nm attributed to the Microcon YM-3 
molecular weight cut-off filters. This technique also, however, had the highest 365 nm 
peak, which suggested the presence of excess unattached cage compound. This was 
due to the lack of secondary washes, which were later performed.  Upon completion of 
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four additional washes of 33% DMF, excess caging compound was removed.  The next 
highest peak in this case was attributed to the sample run through the Sephadex G-25 
column, while the lowest peak was ascribed to the dialysis sample. Complications with 
the organic solvent mixture of DMF caused corrosion of the membrane of the Slide-a-
Lyzer cassettes used to dialyze the sample.  Compatibility of the DMF reaction with this 
technique is unlikely to be very effective when used regularly.  
In Figure 3.8, it was observed that in the case of phosphorothioate DNA ODNs, 
the highest peak was again found with the Microcon YM-3 filters, however the Slide-a-
Lyzer nearly matched it. The Sephadex filter had a very minute peak, and thus showed 
a low ability to filter out this reaction when phosphorothioate DNA ODN is used.  This 
may be due to swelling or other alteration of the Sephadex matrix in the presence of 
DMF.  Looking at Table 3.2, the efficiencies of the samples follow a similar pattern. The 
highest yield with phosphodiester DNA could be noted in the Microcon YM-3 filters.  
Although it had the highest caging efficiency of the three methods, this was improved by 
the multiple washes.  Phosphorothioate samples presented the Slide-a-Lyzer unit as the 
most efficient in DNA recovery and excess cage removal. This would likely have differed 
if secondary washes were performed with the Microcon YM-3 filters. Cost also became 
an issue when presented with the dialysis technique, as was the time required.  The 
cost of the Slide-a-lyzer technique cost more than four times that of the Microcon YM-3 
filters, which also require approximately four hours to complete purification.  This is 
much shorter than the overnight dialysis process. The gel electrophoresis run for each 
set of samples, seen in Figures 3.9 and 3.10, provided evidence that hybridization 
control was attained through the caging reaction. The samples shown provided an 
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insight into reduced mobility for caged samples along with reduced stain attachment.  
Once exposed to UV-light of 365 nm in wavelength, increased mobility as well as 
improved staining provides evidence of the control of hybridization.  The molecular 
beacon hybridizations in Figures 3.11 and 3.12 confirm the results attained from the gel 
electrophoresis. Although hybridization was not very well restored in the 
phosphorothioate samples, these samples were characterized as more heavily caged, 
and so may have required longer exposure with the 365 nm light.  Restoration of the 
ability to hybridization is shown in Figure 3.11, where caged samples remained at low 
levels, and were restored to nearly 4 times the relative fluorescence of the caged ODNs  
once exposed to the 365 nm light.  
Table 3.4. Purification Technique Comparison. 
 
Based on cost and the other factors, we can see in Table 3.4 below that the 
Microcon YM-3 filters showed the most overall promise in the majority of the areas that 
were rated of importance, even though they were not the best in the experiment with the 
phosphorothioate samples. Recovery of the ODNs becomes of great importance when 
phosphorothioate ODNs are used, as cost of the modified oligonucleotides is greatly 
increased in comparison to the phosphodiester ODNs, and the most consistent DNA 
recovery was shown in the Microcon YM-3 filters.  The time factor was also important, 
as the dialysis technique was run overnight in order to efficiently purify the samples.  






Volume of Reaction 
filter can hold 
Cost Efficiency 
of Recovery 
Microcon YM-3 Yes 500 µL Low High 
G-25 Sephadex Yes 50 µL High Mid 
Slide-a-Lyzer No 500 µL Mid Mid 
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 The overall results of this study provide clarity in choosing a solvent in which to 
run and characterize caging reactions.  DMF has proven to be the most appropriate 
solvent, and adequately oxidizes the DMNPE hydrazone precursor into the activate 
diazoethane.  Of the solvents, DMF was the most consistent at compatibility with the 
purification methods, and allows for adequate spectral characterization.   DMF also 
seemed to have little complication with the chosen purification method of the Microcon 
YM-3 filters.  These filters provided adequate volume to purify an entire caging reaction, 
as well as to be completed rapidly when compared to dialysis.  Due to its low cost in 
comparison to the other two techniques, the Microcon YM-3 filter also gives the highest 
DNA recovery.  This combination of solvent and purification technique was suitable for 








Conclusions and Future Considerations 
Conclusions 
 The control of oligonucleotides has become an important focus in the 
development of gene therapies.  By controlling the ability for oligonucleotides to 
hybridize, a more effective approach to using oligonucleotides for a multitude of 
purposes can be developed.  The purpose of this research was to develop a method to 
control DNA oligonucleotides through the use of photo-cleavable cage compounds, thus 
allowing for a spatial and temporal management of DNA.  The presence of the attached 
cage compound has been shown to block hybridization.  The strategy was to provide a 
simple, efficient method through which light could be used as a trigger for hybridization 
activation.  While the use of such control methods has been studied with mRNA and 
DNA plasmids reacted with cage compounds, little in depth study has been placed on 
DNA oligonucleotides (Ando 2001).  We have demonstrated in several bioassays that 
caging DNA oligonucleotides, both modified and unmodified, can block the DNA’s 
capacity to hybridize.  We were also able to show that once exposed to near UV-light, 
restoration of hybridization is partially restored to the DNA oligonucleotides. 
 DNA oligonucleotides were reacted with the cage compound 1-(4,5-dimethoxy-2-
nitrophenyl)diazoethane (DMNPE) in order to temporarily block hybridization activity 
that could later be restored with exposure to light.  Spectrophotometry data 
demonstrated that cage attachment had occurred during the reaction, and this was also 
confirmed through the use of non-denaturing gel electrophoresis.  Through the use of 
molecular beacon hybridization assays, we were able to demonstrate that control of the 
 68
caged DNA oligonucleotides functionality was evident.  In our studies, the caged 
oligonucleotides demonstrated less than 15% of the activity shown by the native (non-
caged) oligonucleotides.  Once exposed to light, these samples restored much of their 
hybridization activity, reaching nearly 80% of that of the native oligonucleotide.  
Qualitative analysis of these molecular beacon hybridizations were performed using 
non-denaturing gel electrophoresis, and provided confirmation of the results attained 
from the molecular beacon assays.   
 The utility of the cage compounds in controlling the hybridization activity of DNA 
oligonucleotides was not limited to standard phosphodiester DNA oligonucleotides.  The 
caging method was shown to be more reactive with the modified phosphorothioate DNA 
oligonucleotides, and reduced hybridization activity with even greater consistency than 
with the phosphodiester oligonucleotides.  Once again, this reaction was demonstrated 
through the use of spectrophotometry, molecular beacon hybridization, and gel 
electrophoresis assays.  The more reactive phosphorothioate oligonucleotides  
demonstrated much greater reduction in hybridization activity than that of the 
phosphodiester oligonucleotides, although restoration of activity proved much less 
efficient. This restoration did recover activity from caged values as low 2% to light 
exposed values of 35% of the hybridization activity of the native oligonucleotide.  This 
was most likely attributed to the heavier caging, and thus may require exposure to light 
for longer amounts of time or under more intense energy, as well as to a lower quantum 
yield for DMNPE caging of a target when sulfur modifications are present (Walker 
1988). 
 Solvent and purification technique studies provided optimization of the caging 
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reaction and the purifications of samples.  N,N-dimethylformamide (DMF) was retained 
as the solvent used in the caging reactions of the ODN.  It provided the most effective 
caging, while also allowing for adequate and proper purification.  Although the spectral 
interference caused by the absorbance of light by DMF from 200 to 260 nm provided 
some concern, the benefits provided from using the solvent greatly outweighed this 
drawback.  Use of Microcon YM-3 filters provided the optimal purification of the ODNs in 
comparison to the other techniques studied.  With the addition of secondary washes to 
the filtration process, optimal purification of the caged ODNs was achieved.  
 In an effort to develop greater sensitivity in the molecular beacon assays, 
experiments were run to help provide a more accurate understanding of the 
hybridization ability of caged and caged-flashed oligonucleotides at various 
temperatures.  Applications of this study could help to provide a better understanding of 
the likelihood of improper hybridization in vivo.  These oligonucleotides were also run in 
comparison to base mismatched oligonucleotides, which have previously been shown to 
have differing hybridization activity at varying temperatures (Bonnet 1999; Tsourkas 
2002; Tsourkas 2003).  The study demonstrated that there is little effect of temperature 
on the hybridization activity of caged and caged-flashed oligonucleotides when 
compared to the native and base mismatched samples. 
 In conclusion, the data presented has shown that the use of cage compounds 
can provide a photo-cleavable method for spatial and temporal control the hybridization 
activity of oligonucleotides.  This also provides a strategy for future application of this 
strategy as a tool in providing targeted antisense and RNAi drug delivery and 
application.   
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Future Considerations 
 Findings of this project showing the ability to photo-control DNA oligonucleotide 
hybridization activity through the use of the cage compound DMNPE provide great 
promise for future development of cage compounds with respect to genetic therapy.  
The use of cage compounds can differ for each individual study, however several other 
cage compounds other than DMNPE have been used with DNA and RNA.  6-bromo-7-
hydroxycoumarin-4-ylmethly (BHC) was used by Ando to cage mRNA in zebrafish 
embryos (Ando 2001).  Use of other caging compounds such as 4,5-Dimethoxy-2-
nitrobenzyl bromide (DMNB) may provide a less expensive technique for achieving 
similar results to those seen with DMNPE.  DMNB has previously been demonstrated to 
cage hydroxyls on β-ecdysone and estradiol as a means to control gene expression 
(Cruz 2000; Lin 2002).  It may provide another, possibly more efficient, method for 
achieving spatial and temporal control of DNA oligonucleotides. 
 Further studies into purification techniques of the samples may also prove 
beneficial to future research.  The issue of solvent compatibility has lead to much 
concern when dealing with cage compounds that are minimally soluble in water, and 
thus can cause issues.  By developing more improved purification techniques and 
protocols, better knowledge of the caging method can be achieved.  Initial studies 
shown in chapter showed that filtration of caged samples once exposed to light, helped 
to remove the released cage molecule and prevent any interference with the assays.  
Scavenger compounds such as dithriothreitol (DTT) are another possible technique that 
could bind the released nitrosoketone and prevent it from causing any interaction 
problems for hybridization.  DTT is also permeable to cell membranes, and thus could 
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be an important tool when caging is used with antisense technologies.  Functional 
separation of the caged oligonucleotides from the non-caged oligonucleotides remaining 
in the samples could also help improve efficiency as well as reduce leakage in the case 
of antisense oligonucleotides.  One technique that could be used would be attachment 
of ODNs complementary to our caged ODN.  By hybridizing with the non-caged ODNs 
in the solution, the ODNs attached to the beads may functionally separate the caged 
oligonucleotides, thus reducing the risk of non-caged oligonucleotides interfering with 
assays or possibly causing leakage in antisense activity prior to light exposure if in vivo.   
 Currently, the caging reaction is performed with random attachment of DMNPE to 
the target oligonucleotides, and thus leads to increased and varied amounts of cage 
compound attached to the target, and requiring greater light-exposure in order to restore 
activity.  Studies of base mismatch location provide insight onto a method to account for 
this, and improve the efficiency of the caging of oligonucleotides, and minimizing the 
light exposure required.  Studies by Bonnet indicated that the location of base 
mismatches along an oligonucleotide affected the ability for the oligonucleotide to 
hybridize, especially noted at 37ºC, which is the standard temperature within a healthy 
cell (Bonnet 1999).  By synthesizing the oligonucleotides with cage compounds in 
specific sites along the sequence, the effectiveness of this control method could be 
greatly augmented.  By determining the most appropriate attachment sites for the cage 
compound along the specific sequence in question, improved photo-restoration of 
hybridization can be achieved.  This can become extremely important if used for 
antisense therapies, as less exposure of cells and tissue to UV-light reduce the risks of 
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cell damage.  Use of two-photon photolysis as described in chapter 1 can also be used 
as a means to reduce risk of cellular damage. 
 Improved molecular assays for determining the effects of cage compounds on 
oligonucleotides would also be of great benefit to future studies of the use of cage 
compounds to control ODNs.  By improving molecular beacon assays through 
temperature variation, greater sensitivity can be used to verify the effectiveness of a 
cage compound in controlling hybridization activity.  Studies focusing on other 
phosphate backbone and base modifications along an oligonucleotide could provide an 
insight on ways to improve this technology. This would also help to possibly provide 
further understanding and confirmation of the location of attachment of the cage 
compound when reacted with nucleic acids.  It could also confirm the effectiveness of 
the temperature varying molecular beacon hybridization to properly represent the 
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Appendix A: Molecular Beacon Temperature Assays 
Introduction 
 The sensitivity of molecular beacons to their targets has been a new area of 
interest in the field.  Several studies have demonstrated how accurately the molecular 
beacons would be able to distinguish their target from other similar sequences, 
including those with only a single base alteration (Tyagi 1998).  Shorter loop regions 
show more interference with a single base mismatch on hybridization (Aboul-ela 1985).  
This specificity is affected by several conditions including pH, salt concentration, and 
temperature.  Looking at temperature, several studies have demonstrated an increase 
in mismatch discrimination of the molecular when temperature is increased to certain 
levels (Bonnet 1999; Tsourkas 2002; Tsourkas 2003).  These studies showed 
significant decreases in the hybridization of beacon with targets with as little as a single 
base mismatch, leading to the belief that other modifications to the oligonucleotide may 
have a similar result.   
In this study we focus on the effects of temperature on caged and caged-flashed 
ODNs and their ability to hybridize with molecular beacons.  This would also be in 
comparison with the perfect or native target, as well as two other modified ODNs, one 
with a single base mismatch and the other with two base mismatches.  In order to 
determine the variable specificity of the molecular beacon assay with respect to caged 
and caged flashed ODNs, it was important to look at effects of temperature on the 
caged samples themselves, and compare the results to those retained through standard 
beacon hybridizations. 
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Materials & Methods 
Sample Preparation 
As was described in chapter 2, samples were prepared similarly in this study.  
Samples of caged ODNs (ISIS 2302) were prepared using the same protocol as found 
in Appendix A, and purified using the Microcon YM-3 filters as shown in Appendix B with 
4 secondary washes.  After characterization, the caged samples, along with native 
20mer ODNs (GCCCAAGCTGGCATCCGTCA), a 20-mer single mismatch ODN (T-MM: 
GCCCAAGCTTGCATCCGTCA) and a 20-mer two mismatch ODN (TT-MM: 
GCCCAAGCTTTCATCCGTCA) were all diluted to 400 µL working stocks with a 
concentration of 0.05 µg/µL.  200 µL of the caged sample was then exposed to UV-light 
(365 nm) for 20 minutes and filtered with the Microcon YM-3 filter protocol and 
resuspended back to µL.  
Once prepared the working stocks were then run through molecular beacon 
hybridization.  For each sample, the ODNs were prepared as performed with a 5:1 
molar ratio of target to molecular beacon as follows: 0.305 µg of native (non-caged), 
caged, caged-flashed, T-MM, TT-MM target ODN were each mixed with 0.105 µg of 
complementary molecular beacon in 500 µL solutions of 100 mM NaCl, 1mM EDTA, pH 
7.5.  One sample containing only 0.105 µg of molecular beacon was also prepared in 
identical buffers and brought up to 500 µL.  A seventh solution containing 0.085 µg of a 
5’FAM modified 20-mer ODN identical in sequence to the native was also prepared 
following the same protocol and used as a control.  
Hybridization Reaction and Fluorescence Detection 
100 µL of each of the mixtures was then denatured at 90°C for 5 min and allowed to 
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slowly cool to 25°C over 60 min.  Fluorescence of hybridization solutions was used to 
quantify the hybridization of molecular beacons with ODNs.  Each of the 100 µL 
hybridization mixtures was excited at 492nm and emitted fluorescence quantified at 
515nm in triplicate with a LS55B Luminescence Spectrophotometer (Perkin Elmer, 
Wellesley, MA).   
300 µL from each of the stocks was then placed in 100 µL aliquots into separate 
wells of a 96-well plate and run on an iCycler thermal cycling unit IQ Optical System 
(Bio-Rad Laboratories, Hercules, CA).  Samples were initially brought up to 95 °C and 
held there for 5 minutes, at which point the temperature was decreased 1°C every 
minute until the final temperature of 25 °C was achieved.  As temperature decreased, 
fluorescence readings of all samples were taken for each one °C. The wavelengths of 
light used by the optical system were 488 nm for excitation and 515 nm for emission 
detection.  Samples were initially calibrated dynamically by the iCycler system at 95 °C.   
For dynamic calibration, samples were initially cycled between 60 °C and 95 °C several 
times to ensure that any duplexes would be denatured, at which point the system 
remained at 95 °C and took readings from each sample and normalized their 
fluorescence at 95 °C. 
Results  
Looking at the fluorescence readings shown in Figure A.1, differing amounts of 
hybridization are seen between the several target ODNs.  The relative fluorescence for 
the molecular beacon alone in this experiment has a relatively high fluorescence at 38.9 
RFUs.  It is not very distinct from that of the native as was the case in the experiment 






































Figure A.1.  Relative fluorescence intensities from solutions of molecular 
beacon hybridized with native, single mismatch (T-MM), two mismatch (TT-
MM), caged or caged-light-exposed ODNs.  Molecular beacon alone and the 
FAM ODN are both used as controls.
while the single mismatch ODN (T-MM) has a nearly identical reading at 90.4 RFUs or 
97.0% of native.  This does slightly decrease for the two mismatch ODN (TT-MM) with a 
value of 74.5 RFUs or 67.2% of native ODN when background noise is subtracted.  The 
caged sample had a value of 40.2 RFUs (9.18% of native) that is indicative of effective 
caging, and was restored to 62.1 RFUs (43.7% of native).  The FAM-labeled ODN 
showed the highest fluorescence at 144 RFUs, which is expected since no quencher is 
present in the solution. 
Relative fluorescence readings are shown in Figure C.2 for the samples at 
various temperatures and the effects of temperature change on the target ODNs.  
Molecular beacon alone follows its standard path at a value of 1449 RFUs at 25°C and  
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Figure C.2.  Temperature varied relative fluorescence intensities from 
solutions of molecular beacon hybridized with native, single mismatch (T-
MM), two mismatch (TT-MM), caged or caged-light-exposed ODNs.  
Molecular beacon alone and the FAM ODN are both used as controls. 
slowly increasing to 3198 RFUs at 95°C. The native ODN resulted in the highest 
fluorescence slowly increasing until peaked at 4014 RFUs at 54°C, and then returning 
to a similar 95°C value as that of molecular beacon alone.  Similarly the single base 
mismatch ODN (T-MM) a slight increase from 25°C peaking at 3078 RFUs at 41°C, 
while the two base mismatch ODN (TT-MM) began to immediately decline from its 25°C 
fluorescence value of 2002 RFUs. For the caged and caged-flashed samples little 
change occurred from the 25°C values of 1163 and 2010 RFUs, respectively and then 
both following the molecular beacon alone trend after 45°C.  The FAM ODN had a 
unique trend of steadily escalating in fluorescence as temperature increases from 25°C 
(2458 RFUs) to 95°C (3323 RFUs). All of the samples showed a similar amount of 
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fluorescence at 95°C due to the dynamic normalization run by the iCycler system prior 
to the performance of readings.  
Discussion 
 The data from this study suggest that the effects of temperature on the 
discriminating ability of molecular beacons are dependent on the type of modification of 
the native ODN.  In the case of the room temperature assays seen in Figure A.1, very 
little difference existed between native ODN and the single base mismatch ODN.  The 
fluorescence slightly lowers as the number of base matches increased to two, as seen 
in the two base mismatch ODN, dropping from 96.97% of native in the single mismatch 
(T-MM) ODN to 67.15% of native for the double mismatch (TT-MM) ODN.  The caged 
ODNs followed expected patterns by reducing hybridization to 9.18% of native, and 
once photo-exposed returning up to 43.73% of native fluorescence.  This demonstrates 
that caging has a much greater affect on reducing hybridization ability than does a one 
or two base mismatch.   
 Temperature effects on the ability of these ODNs to hybridize followed previously 
reported findings.  Effects of temperature on the mismatched ODNs versus that of the 
native ODN showed very similar results to studies performed by Tsourkas and Bonnet 
(Bonnet 1999; Tsourkas 2002; Tsourkas 2003).  As the temperature increased from 
25°C, characteristic decreases in the base mismatch ODNs could be seen.  Initially, TT-
MM ODN began to reduce as soon as the temperature was greater than 25°C.  The T-
MM ODN similarly followed this pattern, however its peak was noted at 41°C, prior to its 
decrease in fluorescence.  In comparison to the native ODN, increases in the number of 
base mismatches lead to lower melting temperatures for the hybridized duplex of the 
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ODN and molecular beacon, as was seen in previous studies (Bonnet 1999).  The 
native ODN reached its peak fluorescence at 54°C, thus providing an optimum 
temperature range of 52°C to 57°C at which to take readings for the most favorable 
discrimination between samples containing perfect target and single base mismatched 
target. 
In the case of the caged and caged-flashed ODNs, very little change was noticed 
based on temperature outside of the behavior of the beacon alone.  The caged sample 
remained below that of the molecular beacon alone at room temperature, and did not 
increase in fluorescence substantially until the temperature was greater that 45°C.  The 
case was similar for the caged-flashed ODN, which although much higher at room 
temperature than the molecular beacon alone, there was little increase until this 45°C 
point.  In comparison to native, these two samples were much lower in fluorescence, 
and increases in temperature showed little increase in the sensitivity of the molecular 
beacon with respect to caged samples.  This is possibly due to the modification of the 
backbone theorized to take place in caging, as opposed to the base modifications seen 
in base mismatched ODNs.  In modifying the backbone, increased suppression may be 
attainable, however hybridization of these caged samples may not be affected by 
temperature as is the case with the FAM ODN, which has much less fluctuation with 






Appendix B:  Caging Protocol for ODN DNA 
 
a. Activate DMNPE: 
In a plastic weigh boat, weigh approximately: 
 
5 mg 4,5-dimethoxy-2-nitroacetophenone hydrazone (yellow crystals, 
stored at –20 °C) 
 
50 mg Manganese (IV) oxide (black pellets, stored at 25 °C ) 
  
Transfer to a 1.5 ml eppendorf and wash in 1 ml DMSO (clear viscous 
liquid, stored at 25 °C).  Protect the eppendorf from light from this point 
onwards by shielding it with aluminum foil.  Vortex the solution for 15 sec., 
then rock on a NutatorTM  for 20 min.   
 
Before filtering, microfuge the solution for 30 sec. to draw large particles of 
MnO2 to the bottom of the tube to prevent filter clogging.  Solution should 
look murky and dark reddish-brown. 
 
b. Filter MnO2 from activated DMNPE: 
 
a) Pack a 1 cc syringe with glass wool 
 
b) Add 100 mg of CeliteTM diatomaceous earth (use a syringe w/ 
stopper removed to poke the glass wool & Celite to the bottom.) 
 
c) Pre-wet the filter with 1 ml DMSO 
 
d)  Remove the top 900 µl of microfuged cage solution and gently 
push through filter.  Effluent should be a clearer red solution. 
 
e) Microfuge this solution as well for 30 sec to ensure that any MnO2 
that possibly passed through the filter will not be added to the 
caging reaction (MnO2 will oxidize DNA as well.) 
 
c. Prepare DNA and add activated cage: 
 
a) ODNs were kept in either 10 mM Bis-Tris or HPLC Grade water.  
For a reaction, 100 µg of DNA is brought up to 200 µl of 10 mM 
Bis-Tris in a 1.5 ml eppendorf.  100 µl of the activated cage 
solution is then added, vortexed briefly, and then put in an agitator 
for 24 hrs at 4 °C. 
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Appendix C: Purification Techniques 
I. Sephadex Spin Columns 
b. Dry down reaction volume(s) in vacufuge until precipitate forms (can take 
several hours, however DMF is volatile enough to be removed. 
 
c. Resuspend the sample into 100 µL of 0.2 µm-filtered water. 
 
d. Column preparation 
 
i. Flick tube or vortex for a few moments to try and spread buffer 
through out column.  
 
ii. To prevent a vacuum, first remove cap of column, then snap off 
bottom tip. 
 
iii. Place column(s) into clean, empty 1.5 mL Eppendorf tubes and 
place in microcentrifuge for 75 seconds at 1000 x g. Ensure that 
chipped edge of columns all face towards center of microfuge. 
 
iv. Discard buffer solution in eppendorf and run 300 µL of 0.2 µm 
filtered water through the column and place in micro centrifuge for 
3 minutes at 1000 x g. 
 
v. Remove tube and place column into a new, sterile 1.5 mL 
Eppendorf tube. 
 
II. Slide-a-Lyzer Dialysis 
a. Hydrate Membrane 
 
i. Remove Slide-A-Lyzer® Cassette from its pouch and slip into the 
groove of an appropriate size buoy. 
 
ii. Immerse cassette in dialysis buffer for 30 seconds. 
 
iii. Remove cassette from buffer and remove excess liquid by tapping 
the edge of the cassette gently on paper towels. 
 
b. Add Sample 
 




ii. With the bevel sideways, insert the tip of the needle through one of 
the syringe ports located at a top corner of the cassette. 
 
iii. Inject sample slowly. Withdraw air by pulling up on the syringe 
piston. 
 





i. Slip the cassette into the groove of the buoy and float this assembly 
in 300 mL of the dialysis solution of 33% DMF.  
 
ii. Leave in Dialysis solution at room temperature at room temperature 
for 4 hours. 
 
iii. Change the dialysis buffer solution and let dialyze for another 4 
hours at room temperature. 
 
iv. Change the dialysis buffer solution and let dialyze overnight at 4 °C. 
 
d. Remove Sample 
 
i. Fill the syringe with a volume of air equal to the sample size and, 
with the bevel sideways, insert the tip of the needle through another 
syringe port located at a corner of the cassette. 
 
ii. Inject air slowly into the cassette to separate the membranes. 
 
iii. Turn the unit so that needle is on the bottom and allow the sample 
to collect near the port. Withdraw the sample into the syringe. 
 
III. Microcon YM-3 Molecular Weight Cut-off Filters 
a. Remove a filter and accompanying 1.5 mL centrifuge tube. Place filter 
properly in tube. 
 
b. Place up to 500 uL of sample into the filter, seal cap, and place into 
microcentrifuge.  
 
i. Be sure to counterbalance the weight of the tube, filter, and sample 
once in the centrifuge. 
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c. Spin sample at maximum speed (13,400 RPMS, approximately 12,000 
g’s) for 90 minutes at room temperature. 
 
d. Once complete, add 100 uL of 33% DMF solution to wash sample, and 
spin again for 30 minutes. 
 
e. Repeat step “d” three more times. 
 
f. Once complete, flip over the filter and place into a new fresh centrifuge 
tube, and spin in centrifuge at 1000 g’s for 3 minutes.  
 
g. Once complete, remove filter and discard. Keep centrifuge tube with newly 
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